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ABSTRACT 
This thesis investigated the ultrasound assessment of the endometrial-myometrial junction 
(EMJ) and its clinical relevance to the uterine diseases, adenomyosis and endometrial cancer. 
The inter- and intraobserver variability in the classification of EMJ visualisation using three-
dimensional ultrasound was assessed and a high level of agreement was found. Endometrial 
thickness and parity were found to be significantly associated with the quality of EMJ 
visualisation.  
 
Seven recognised ultrasound features of adenomyosis, including an irregular endometrial-
myometrial junction, were investigated for their role in the ultrasound diagnosis of 
adenomyosis. The other features were an asymmetrically thickened myometrium, parallel 
shadowing, linear striations, myometrial cysts, hyperechoic lesions and adenomyomas. The 
presence of any of these features was considered diagnostic of adenomyosis. The inter- and 
intraobserver variability of ultrasound diagnosis of adenomyosis was also investigated and a 
good level of agreement was found. This was the case when real-time ultrasound assessments 
were compared with assessments made from stored uterine volumes, as well as when both 
assessments were made from stored volumes. 
 
Transvaginal ultrasound was used to assess the prevalence of adenomyosis in women 
attending a general gynaecology clinic in a large prospective observational study. Women 
were considered to have adenomyosis if one or more ultrasound feature of adenomyosis was 
found. Using this criterion, the prevalence was estimated to be 20.9% with 7.6% of women 
being excluded from the data analysis. It was also found that age, gravidity and pelvic 
endometriosis were all significantly associated with the presence of adenomyosis. 
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Menorrhagia was evaluated in order to assess if it was associated with adenomyosis. 
Multivariable analysis revealed that while adenomyosis was not significantly associated with 
menorrhagia when assessed as a binary outcome, when severity of disease was taken into 
account, there was a significant association. A similar analysis found that adenomyosis was 
significantly associated with dysmenorrhoea. 
 
A second-stage ultrasound test that incorporated assessment of the EMJ was investigated for 
its use in the diagnosis of endometrial cancer in women presenting with post-menopausal 
bleeding. It was found to significantly increase the specificity of ultrasound in the diagnosis 
of endometrial cancer while having a minimal impact on sensitivity. 
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HYPOTHESIS 
 
This thesis will investigate the following hypotheses: 
 Three-dimensional transvaginal ultrasound can be used as an accurate and 
reproducible method for assessment of the endometrial-myometrial junction. 
 Transvaginal ultrasound is an accurate and reproducible imaging modality for the 
diagnosis of adenomyosis and for assessment of its severity 
 Adenomyosis is a common condition 
 Adenomyosis is associated with both menorrhagia and dysmenorrhoea 
 Ultrasound assessment of the endometrial-myometrial junction can be used to 
improve the accuracy of transvaginal ultrasound in the diagnosis of endometrial 
cancer 
20 
 
AIMS 
The aims of this thesis are: 
 To examine the reproducibility of three-dimensional ultrasound assessment of the 
endometrial-myometrial junction 
 To examine the reproducibility of ultrasound diagnosis of adenomyosis using three-
dimensional stored uterine volumes 
 To determine the prevalence of ultrasound features of adenomyosis in a population of 
women attending a general gynaecology clinic, using transvaginal ultrasound. 
 To determine if adenomyosis is associated with menorrhagia and dysmenorrhoea 
 To evaluate a second-stage test, incorporating assessment of the endometrial-
myometrial junction, designed to improve the accuracy of transvaginal ultrasound in 
the diagnosis of endometrial cancer 
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PART I BACKGROUND 
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1.0 TECHNICAL ASPECTS OF ULTRASOUND 
1.1 Introduction 
Ultrasound has transformed many aspects of gynaecological practice. Prior to its use in 
medicine, diagnosis of gynaecological conditions was based almost entirely on clinical 
examination, surgical and histological findings. The first published clinical use of ultrasound 
was in the field of gynaecology when Professor Ian Donald and his registrar John McVicar 
used transabdominal ultrasound to differentiate between solid and cystic abdominal masses 
(Donald et al. 1958). Professor Donald combined his clinical experience and his knowledge 
of SONAR, gleaned during World War II, with the technical expertise of Tom Brown, an 
engineer with an interest in the use of ultrasound in metallurgy, to create and use the first 
clinically useful ultrasound machine. The ability to provide instant, clinically useful 
information using a safe, non-invasive modality was transformational and has revolutionised 
gynaecological practice. There have been many significant technical advances, most recently 
three-dimensional (3D) ultrasound, yet it is still B-mode ultrasound, first used by Donald and 
his team over 50 years ago, that is the primary imaging tool in gynaecology today. 
 
1.2 Principles 
Medical ultrasound is based on the principle of passing a current through a piezoelectric 
crystal to create ultrasound pulses, which can then be transmitted through the relevant body 
tissue. When these pulses encounter an interface between tissues of differing acoustic 
impedance or density, a proportion of the emitted soundwaves will be reflected back towards 
the piezolelectric element from which they were emitted (echoes). The echoes are then 
converted into an electric current, the amount of current produced being dependent on the 
number of echoes received. The conversion of this current into an image therefore gives a 
visual representation of the varying densities within the body tissue. 
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1.3 Image formation 
1.3.1 Brightness mode image formation  
A brightness-mode or B-mode image is a cross-sectional image representing tissues and 
organ-boundaries within the body. The image is constructed from echoes generated by the 
reflection of ultrasound waves at tissue boundaries. Each echo is displayed at a point in the 
image which corresponds to the position of its origin in the tissue being isonated. The 
brightness of the image at each point is related to the strength or amplitude of the echo, 
giving rise to the term brightness mode or B-mode (Martin 2003). 
 
1.3.2 Transvaginal ultrasound 
The frequency of ultrasound pulses used is a compromise between image resolution and the 
depth of penetration required. Higher ultrasound frequency results in better image resolution 
but there is greater attenuation of the beam within the tissues. Therefore, transabdominal 
ultrasound probes, which have to pass through multiple tissue layers before reaching the 
abdominal cavity, tend to use lower frequencies (3.5-5MHz) at the expense of image 
resolution. The ability of transvaginal ultrasound (TVUS) probes to get much closer to the 
organs of interest, enables the use of higher frequencies (8-15MHz) leading to improved 
image resolution. 
 
1.4 Doppler  
1.4.1 The Doppler effect 
The Doppler effect is the apparent difference between the frequency at which waves (sound 
or light) leave a source and that at which they reach an observer, caused by the relative 
motion of the observer and the wave source (McNay and Fleming 1999). The effect takes its 
name from the Austrian physicist Christian Johann Doppler who presented the idea in 1842 
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(Roguin 2002).When the object emitting the waves is stationary the observed frequency is the 
same as the emitted frequency, however if the sound source is moving towards the observer, 
the experienced frequency is higher as the sound waves become more compressed and the 
opposite happens if the sound source is moving away from the observer. This change in 
frequency is called the Doppler shift and is proportional to the relative velocity of the source 
to the observer. 
This effect can be applied clinically and is widely utilised in both obstetric and 
gynaecological ultrasound in order to assess the velocity of blood flow through blood vessels. 
When the ultrasound beam is reflected off moving blood, there are two Doppler shifts, one 
when the transmitted ultrasound strikes circulating blood cells and a second when circulating 
blood cells emit the reflected ultrasound. Evaluation of these Doppler shifts, alongside 
knowledge of the transmitted ultrasound frequency, the velocity of sound through the tissue 
and the angle of insonation, allow the calculation of the velocity of blood passing through the 
vessel (Hoskins et al. 2003). This estimated velocity of blood flow over time can be shown on 
the ultrasound machine as a tracing (Figure 1). 
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Figure 1 – Image capture showing B-mode ultrasound image with Doppler velocimetry of a 
blood vessel within a malignant ovary (short white arrow). The graph at the bottom (long 
white arrow) is the tracing showing the estimated velocity of blood flow through the blood 
vessel (y-axis) over time (x-axis). 
 
 
1.4.2. Colour Doppler Imaging 
In colour Doppler scanning, the same process is applied across an area of tissue rather than a 
specific blood vessel. The velocity signals are presented as a colour coded overlay, 
superimposed on the real-time B-mode image. This allows production of an angiogram-like 
map that provides information on the morphological arrangement of the vascular tree in the 
tissue of interest. While its sensitivity is good enough to enable visualisation of vessels 
smaller than one millimetre (De Souza and Cosgrove 2003), it is restricted by its reliance on 
frequency shifts. 
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Figure 2a –B-mode image of uterine corpus (long white arrow) and a pelvic mass (short 
white arrow) with appearances suggestive of a uterine fibroid. 
 
 
Figure 2b – B-mode image of same uterine corpus and pelvic mass, with colour Doppler 
illustrating the vascular pedicle connecting the uterus and the pedunculated fibroid. 
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1.4.3 Power Doppler Imaging 
Power Doppler has greater sensitivity than colour Doppler imaging, because the display 
depends on the amplitude of Doppler signal rather than the frequency shift. Thus, power 
Doppler imaging provides information on the concentration of moving blood at the expense 
of knowing its velocity and direction. In addition to being more sensitive than colour Doppler 
imaging, it is relatively angle independent, more accurate in depicting luminal edges and 
better in visualising the continuity of flow (Rubin 1999). 
 
Figure 3 – TVUS image showing an endometrial polyp with its ‘feeder’ vessel delineated by 
power Doppler. 
 
 
1.5 Three-dimensional ultrasound 
3D ultrasound is a relatively recent diagnostic modality, which allows detailed evaluation of 
pelvic organs by collecting a series of sequential ultrasound images and converting them into 
an ultrasound volume. This information is digitally stored as a dataset which is reconstructed 
in such a way as to allow visualisation of an organ from any chosen angle and in any arbitrary 
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plane (Jurkovic 2002). In the field of obstetrics and gynaecology 3D ultrasound has so far had 
the greatest impact on the diagnosis of uterine abnormalities. 
 
1.5.1 Three–dimensional ultrasound volume acquisition 
3D ultrasound involves the acquisition of a series of consecutive, parallel B-mode images by 
sequential movement of either the transducer or the ultrasound beam. This series of images is 
then stored in the computer as a volume set which can be examined using three methods: 
section reconstruction, surface rendering and volume rendering. The 3D ultrasound 
equipment used in this thesis is designed by Kretz Technik, Zipf, Austria (Voluson E8). This 
commonly used system combines both short volume acquisition time and fast computing, 
enabling almost immediate online data analysis and near real-time surface rendering. Volume 
acquisition with this system is performed using mechanical movement of the ultrasound 
transducer within the transvaginal probe. 
An important aspect of 3D ultrasound is the ability to display and manipulate any chosen 
section from within the dataset. This confers many advantages over B-mode imaging. Firstly, 
it allows the acquisition of views that are not possible with conventional two-dimensional 
sonography, largely as a result of restrictions on probe movement imposed by pelvic anatomy 
(Baba et al. 1997). The example of this most relevant to this thesis is the coronal view of the 
normal female uterus (Figure 4). Secondly, the ability to view the organ in three orthogonal 
planes enables a more detailed analysis of the organ to be performed. Finally, the storage of 
images for manipulation enables examination of the volume set by multiple operators at 
different times. 
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Figure 4 – A 3D coronal view of a normal uterus. 
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2.0 ENDOMETRIAL-MYOMETRIAL JUNCTION (EMJ) 
2.1 Introduction 
Assessment of the uterus has historically focussed on what were considered to be its two 
constituent parts: the endometrium and the myometrium. Magnetic resonance imaging (MRI) 
studies in the early 1980s revealed that the myometrium might be further divisible into two 
distinct compartments: the inner and outer myometrium (Hricak et al. 1983). Despite being 
macroscopically and microscopically indistinct, subsequent research has shown these two 
compartments of the myometrium to have quite different embryology, anatomy and 
physiology. The inner myometrium has been variously termed the uterine junctional zone 
(JZ) (Fusi et al. 2006), the endometrial-subendometrial unit or stratum sub-vasculare
 
(Noe et 
al. 1999), the subendometrial myometrium (Lyons et al. 1991) the archimetra
 
(Leyendecker et 
al. 1998) or archimyometrium
 
(Leyendecker et al. 2006). While these terms are often used 
interchangeably it is not always clear whether they are referring to exactly the same entity. 
For the purposes of this thesis, this region will be referred to as the EMJ. It is the transitional 
zone between the mucous membrane that is the endometrium and the outer smooth muscle 
layer of the myometrium (Figure 5). 
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Figure 5 - Schematic diagram of a uterus in transverse section showing the endometrial and 
myometrial layers and the EMJ (Naftalin and Jurkovic 2009). 
 
 
2.2 Embryology of the EMJ 
The endometrium and the EMJ both arise from the paramesonephric ducts, whereas the outer 
myometrium is of mesenchymal origin (Daels 1974; Brosens et al. 1998) The 
paramesonephric ducts are formed at about six weeks’ gestation from the coelomic 
invagination of mesodermal cells at the level of the third thoracic somite (Koff 1933; 
O’Rahilly 1977). The caudal portions of these tubes make contact with each other and fuse in 
the midline, giving rise to the uterus and vaginal canal. The septum that initially divides the 
uterine cavity is then reabsorbed leaving a single cavity. The endometrial glands originate at 
around 19 weeks’ gestation from out-pouchings of the columnar epithelium that lines the 
primitive uterine cavity. The smooth muscle cells of the EMJ can be seen from around 21 
weeks, while the outer layers of the myometrium develop in the third trimester or even 
postnatally (Noe et al. 1998). 
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2.3 Anatomy and histology of the EMJ 
The myometrium consists of bundles of smooth muscle fibres, intermixed with areolar tissue, 
blood vessels, lymphatic vessels, and nerves. The muscle fibres of the EMJ have 
predominantly circular orientation, in contrast to the longitudinal smooth-muscle orientation 
of the outer layers of myometrium (Wetzstein and Renn 1970). The endometrium, the 
mucous membrane that lines the uterine cavity, is composed of a single layer of columnar 
epithelium. 
The EMJ is structurally distinct from other mucosal-muscle interfaces within the human body 
in that it lacks a submucosal layer. Most tissues with a mucosa have a subjacent, 
histologically recognizable submucosa that protects the underlying tissue from mucosal 
invasion, e.g., stomach, intestine, trachea, and bronchi (Marcus 1961, Emge 1962). While the 
superficial and basal layers of the endometrium are clearly distinguishable on light 
microscopy, there is no histological distinction between the inner myometrium and the outer 
myometrium on light microscopy. Tetlow et al.
 
demonstrated increased vascularity of the 
EMJ when compared with the rest of the myometrium and also found that the muscle fibres 
of this zone were more densely packed than in other zones of the myometrium. They 
concluded that these architectural findings would account for the hypoechoic appearance of 
the EMJ on both TVUS and MRI (Tetlow et al. 1999). 
 
2.4 Physiology and hormonal regulation of the EMJ 
The endometrium and EMJ do not just share an embryological origin. While they are 
physiologically distinct, they are both under the cyclical influence of ovarian sex steroids. 
The main function of the EMJ appears to be modulation of uterine peristalsis, an area thought 
to play an increasingly significant role in fertility. Uterine contractions emanating from the 
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EMJ were first visualised and subsequently described by Birnholz who visualised them on 
transabdominal ultrasound (Birnholz 1984). EMJ contractions vary in orientation, amplitude 
and frequency throughout the cycle under the influence of oestradiol and progesterone. In the 
menstrual phase these contractions are fundo-cervical in direction (de Ziegler et al. 2001) 
facilitating menstruation. The direction reverses during the follicular phase becoming 
predominantly cervico-fundal with the amplitude and frequency of contractions increasing 
significantly as ovulation approaches. There is evidence that this pattern of contractions in the 
late follicular phase facilitates sperm transport
 
(Kunz et al.1996). After ovulation there is a 
decrease in overall EMJ contractility under the influence of progesterone. Ijland et al. 
suggested that this may help to facilitate implantation of the developing blastocyst, while 
improving its supply of oxygen and nutrients (Ijland et al.1996). 
  
2.5 Imaging of the EMJ 
Assessment of the EMJ has traditionally been part of the MRI evaluation of the uterus, with 
changes in this area being a key component of the diagnosis of adenomyosis. With regard to 
ultrasound, although the EMJ is visible, it has not historically played a major part in the 
evaluation of uterine pathology. This may be partly due to the fact that in order to obtain clear 
images of the EMJ, high resolution ultrasound equipment with 3D imaging facility is often 
required, which has only been available in recent years. This may also explain why the 
majority of studies addressing visualisation and the appearance of the EMJ have used MRI.  
 
2.5.1 Magnetic Resonance Imaging 
Hricak et al. first described the uterus as comprising three distinct zones when visualised on 
MRI (Hricak et al 1983). MR imaging of uterine zonal anatomy is best demonstrated on T2-
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weighted images. The endometrium is of generally high signal intensity and is therefore 
visualised as a thin white stripe. The inner myometrium or JZ, as most MRI studies refer to 
the inner myometrium, is of uniformly low signal intensity while the outer myometrium is of 
intermediate signal intensity
 
(Lee et al. 1985) (Figure 6). 
 
Figure 6 – Sagittal T2-weighted image of a uterus showing normal zonal anatomy with a high 
signal intensity endometrium (arrowhead), low-signal intensity JZ (short arrow) and 
intermediate signal intensity outer myometrium (long arrow) (Novellas et al. 2011). 
 
 
Because of this observed contrast of the three uterine zones, MRI is very good at delineating 
and measuring the size of these zones. Many studies have attempted to derive a normal range 
for JZ thickness, with the upper limit now considered to be 8mm (Novellas et al. 2011). This 
measurement is crucial in the MRI diagnosis of adenomyosis, which is largely dependent on 
increased thickness of the JZ (Reinhold et al. 1996). It is worth noting that the thickness and 
appearance of the JZ is hormone-dependent and therefore cyclical with the maximal thickness 
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of the JZ being reached during the menstrual phase of the menstrual cycle (Fusi et al. 2006). 
Furthermore, prior to menarche, during pregnancy and after the menopause, uterine zonal 
anatomy is less distinct (Demas et al. 1986; Brosens et al. 1998; Willms et al. 1995) with the 
JZ and the outer myometrium being poorly distinguished. This finding is reversed in 
postmenopausal women by the taking of hormone replacement therapy (McCarthy et al. 
1986). These effects mean that the JZ cannot be measured in a significant proportion of 
women; up to 30% of premenopausal women (Bazot et al. 2001) and 50% of postmenopausal 
women (Fusi et al. 2006). 
 
2.5.3 Ultrasound 
Formal ultrasound examination of the uterus includes a detailed assessment of the 
morphological characteristics of the myometrium and endometrium. These two main 
functional components of the uterus display different acoustic properties, which facilitates 
their differentiation on the ultrasound image. On ultrasound, the inner myometrium has been 
described as a hypoechoic band or ‘halo’ that regularly encircles the endometrium (Kunz et 
al. 2000). While this zone is distinct from both the endometrium and the outer myometrium, 
the ultrasonic delineation of uterine zonal anatomy is less clear than on MRI. Ultrasound, 
however, has the ability to visualise very clearly the basal endometrial layer, which forms the 
actual interface between the inner myometrium and the endometrium.  On two-dimensional 
ultrasound scan, the EMJ is best seen in the longitudinal section, which enables the 
examination of its anterior and posterior aspects. In this view the EMJ is seen as consisting of 
two distinctive structures: basal endometrium and inner myometrium.  In normal uteri the 
basal endometrium is seen as a continuous uninterrupted hyperechoic line and in practical 
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terms it represents the endometrial–myometrial interface (Naftalin and Jurkovic 2009) 
(Figure 7). 
Figure 7 – A TVUS image showing a longitudinal view of a normal uterus in the proliferative 
phase of the cycle. The callipers are placed on the basal endometrial layer which appears as a 
regular continuous hyperechoic line. The surrounding inner myometrium appears hypoechoic 
in comparison to both the outer endometrial and outer myometrial layers (Naftalin and 
Jurkovic 2009). 
 
 
On ultrasound, as with MRI, the differences in appearance of the inner and the outer 
myometrium are influenced by ovarian sex steroid hormone levels. For example, prior to 
menarche when the levels of the ovarian sex steroids are low, just as with MRI, the inner and 
outer myometrium are indistinct on ultrasound
 
(Newren 1997). There are, however, no 
reported ultrasound studies of the cyclical changes seen within the EMJ (Naftalin and 
Jurkovic 2009). 
With the development of 3D ultrasound has come the ability to create a 3D reconstruction of 
uterine anatomy in the coronal plane. This allows ultrasound assessment of both the lateral 
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and fundal aspects of the EMJ, which were otherwise impossible to see clearly on standard B-
mode ultrasound imaging. The ability to see the entire lateral borders of the EMJ in a single 
view has, literally, added a new dimension to the ability to visualise the EMJ on ultrasound. 
Exacoustos et al. applied measurements taken routinely in the MRI assessment of 
adenomyosis to ultrasound assessment of the uterus (Figures 8a & 8b). They took various 
measurements of the JZ taken using a 3D coronal view of the uterus including the minimal JZ 
thickness (JZmin), the maximal JZ thickness (JZmax) and the maximal myometrial thickness, 
as a means of diagnosing adenomyosis (Exacoustos et al. 2011). They considered a JZmax 
>8mm and a difference between the JZmin and the JZmax of >4mm to have high diagnostic 
accuracy however these measurements have not been  tested prospectively and furthermore, 
no studies have been performed that attempt to describe a normal range for JZ thickness, as 
measured by 3D ultrasound.  
38 
 
Figure 8a – A 3D coronal view of a normal uterus showing measurements of the maximal JZ 
thickness (callipers 1 and 4), minimal JZ thickness (calliper 3) and maximal myometrial 
thickness (calliper 2) (Exacoustos et al. 2011) 
 
 
Figure 8b – A schematic representation of Figure 8a 
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2.6 Pathology of the EMJ 
2.6.1 Adenomyosis 
Adenomyosis is a condition defined by the presence of endometrial glands or stroma within 
the myometrium. While there is still much that is poorly understood about the condition, it is 
accepted that it often involves the EMJ, while some would consider it a disease of the EMJ. 
  
2.6.1.1 History of adenomyosis 
Determining the history of adenomyosis, as with many other aspects of the disease, is fraught 
with difficulties. It remains unclear as to when it was first described with Scroen (1690), 
Rokitansky (1860) and Cullen (1896) all being credited (Benagiano and Brosens 2006). 
Further difficulty stems from the fact that for some time, adenomyosis and endometriosis 
were considered to be the same condition. The first detailed descriptions of adenomyosis 
came from Cullen in 1896 (Cullen 1896). He subsequently dedicated an entire book to the 
condition, entitled ‘Adenomyoma of the uterus’ (Cullen 1908). It was Frankl who first used 
the term ‘adenomyosis’ explaining “I have chosen the name of adenomyosis, which does not 
suggest any inflammatory genesis as do terms like adenometritis, adenomyositis and 
adenomyometritis…..We were never able to find any trace of an inflammatory infiltration, 
either in the musculature or the mucosa of this region”. He also noted continuity between 
adenomyosis and the endometrium, suggesting an endometrial origin to the disease (Frankl 
1925). It was with Sampson’s classical description of peritoneal endometrium and the first 
use of the term ‘endometriosis’ two years later, that the conditions started to be considered as 
two separate entities (Sampson 1927). The modern definition of adenomyosis – ‘benign 
invasion of the endometrium into the myometrium’- was provided by Bird et al. in 1972 (Bird 
et al. 1972). 
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2.6.1.2 Pathogenesis of adenomyosis 
The precise pathogenesis of adenomyosis remains unknown with many theories being 
proposed. The most widely held theory is that it results from invagination of endometrial 
tissue, across the EMJ, into the myometrium. There are numerous histological and ultrasound 
reports of endometrial tissue being seen in continuity with adenomyosis within the 
myometrium (Frankl 1925; Ferenczy 1998; Naftalin and Jurkovic 2009; Verma et al. 2009) 
that would appear to corroborate this theory. Other suggested mechanisms for the disease 
include de novo development of endometrial tissue from mullerian remnants, although this is 
thought to apply more to adenomyosis found in extra-uterine sites, such as the recto-vaginal 
septum (Nisolle and Donnez 1997). 
Even if endometrial invagination is the cause, there is still significant uncertainty about what 
factors might trigger this invasion. As with most chronic conditions, the aetiology is likely to 
be multi-factorial involving some or all of the factors described below. The ‘invasive 
potential’ of endometrial tissue has been investigated as a possible cause. In-vitro studies 
have shown that endometrial cells have a similar invasive potential to metastatic bladder cell 
lines (Gaetje et al. 1995). Others have looked for differences between normal endometrial 
glands and ‘adenomyotic’ endometrial glands found in the myometrium. Lei et al. found 
increased expression of human chorionic gonadotrophin (hcg) / luteinizing hormone (LH) 
receptor mRNA in endometrial glands found in foci of adenomyosis, compared with normal 
endometrial glands (Lei et al. 1993). A similarly increased hcg/LH receptor expression has 
been found in endometrial cancer cells when compared to normal endometrium (Lei et al. 
1992), and in invasive trophoblast when compared to non-invasive trophoblast in 
choriocarcinomas (Lin et al. 1994). It is possible therefore that this increased receptor 
expression may be related to the potential of endometrial tissue to invade into the 
myometrium and form adenomyotic foci (Ferenczy 1998). 
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Myometrial characteristics may have a role in this endometrial invasion. The EMJ is unusual 
in lacking a sub-mucosal layer. Most muscle-mucosa interfaces within the body, having a 
distinct subjacent histologically recognizable sub-mucosal layer that protects the underlying 
tissue from invasion (Marcus 1961, Emge 1962). The absence of this layer might explain why 
invasion can occur, but does not explain why it happens in particular areas of the 
myometrium but not others. 
Endometrium may cross the EMJ at areas of myometrial ‘weakness’. A few theories of how 
myometrial ‘weakness’ might occur have been proposed. Surgery provides a mechanical 
model for this. Many studies have looked for an association between adenomyosis and 
uterine surgeries, including caesarean section, uterine curettage and termination of 
pregnancy. All these operations involve operating across or close to the EMJ and could easily 
create defects in the EMJ or myometrium. Indeed, in the case of Caesarean section, it would 
be impossible to perform the operation without breaching the EMJ. Defects in the 
myometrium following Caesarean section are clearly visible on ultrasound and have been 
reported in the literature (Ofili-Yebovi et al. 2008). Studies, however, have not consistently 
found an association between Caesarean delivery and adenomyosis (Bergholt et al. 2001; 
Harris et al. 1985). Uterine curettage might create defects in the myometrium through which 
endometrial tissue might subsequently pass or could even push endometrial tissue through the 
EMJ and into the myometrium at the time of surgery. Adenomyosis has been elicited in 
pregnant rabbits by curetting one uterine horn and leaving the pregnancy in the other horn 
(Lewinski 1931). In human studies, several authors (Levgur et al. 2000; Vavilis et al. 1997; 
Curtis et al. 2002) have found an association between adenomyosis and previous surgical 
termination of pregnancy. Uterine softening in early pregnancy (Munsick 1985) might 
increase the risk of EMJ trauma, perhaps explaining the association reported between 
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adenomyosis and uterine instrumentation in pregnancy, but not outside of pregnancy (Levgur 
et al. 2000; Curtis et al. 2002). 
Since adenomyosis is more common in parous women, mechanical events at parturition have 
been considered to be the main pathogenenic factors for the development of adenomyosis 
(Kitawaki 2006). However there are few data to support that it is parturition rather than 
pregnancy per se that is the cause. Certainly the physiological process of trophoblast 
invasion, common to all pregnancies, involves invasion up to the EMJ. MR images during a 
conception cycle have shown focal changes within the EMJ (Turnbull et al. 1995) and it is 
known that trophoblast invasion is able to progress beyond the EMJ, albeit pathologically, in 
cases of placenta accreta, increta and percreta. Perhaps the process of trophoblast invasion, in 
some women, alters the EMJ leaving it susceptible to adenomyosis in the future. 
Uterine autotrauma, mediated by hyperperistalsis of the inner myometrium, has been 
suggested as a further mechanism by which both adenomyosis and endometriosis might 
spontaneously form. This theory holds that chronic peristalsis or periods of hyperperistalsis in 
the inner myometrium cause EMJ microtrauma and that a cycle of permanent 
hyperperistalsis, mediated by increased oestrogen production, leads to overt autotrauma. This 
combination of hyperperistalsis and overt trauma to the EMJ would physically force basal 
endometrial tissue into the myometrium (Leyendecker et al. 2009) causing adenomyosis. The 
increased presence of oestrogen plays a key role in this hypothesis. Adenomyosis has been 
found to be associated with oestrogen-dependent conditions including uterine fibroids (Azziz 
1989), endometriosis (Kunz et al. 2000), and endometrial hyperplasia (Bergholt et al. 2001). 
It also appears to be most prevalent in women of reproductive age and regresses after the 
menopause (Kitawaki 2006). This has led some researchers to investigate the role of 
oestrogen in the pathogenesis of adenomyosis. It has been reported that oestrogen receptors 
are always found in adenomyotic tissue (Tamaya et al. 1979). Other investigators have found 
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that adenomyotic tissue contains aromatase, an enzyme that catalyses the conversion of 
androgens to oestrogens, suggesting that local oestrogen production within adenomyotic 
tissue may contribute to overall oestrogen concentrations (Urabe et al. 1989). Further 
evidence of this local production of oestrogen comes from a study that looked at oestrogen 
levels in both peripheral and menstrual blood in women with and without adenomyosis. 
While there was no difference in the oestrogen levels in peripheral blood, there were 
significantly increased oestrogen levels in the menstrual blood of women with adenomyosis 
(Takahashi et al. 1989). 
A genetic predisposition to adenomyosis has been suggested from early reports suggesting 
heredity (Emge 1962; Arnold et al. 1995) however few studies have investigated the genetics 
of adenomyosis. Pandis et al. found a common chromosomal abnormality [7] [q21.q231.2] in 
three cases of adenomyosis (Pandis et al. 1995). Similarly Kitawaki found that the PP 
genotype is less frequently observed in women with endometriosis and adenomyosis when 
compared with women with neither condition (Kitawaki et al. 2001). Wang et al. 2002 found 
no chromosomal gain or loss in 25 cases of adenomyosis using comparative genomic 
hybridization (Wang et al. 2002).  
 
2.6.1.3 Diagnosis of adenomyosis 
2.6.1.3.1 Histology 
The histological diagnosis of adenomyosis requires endometrial glands or stroma to be found 
beyond the EMJ and up until relatively recently, histopathological examination of the uterus 
was the only way to diagnose the condition. While recent advances in imaging make an 
accurate, non-invasive diagnosis possible, almost all the published studies of the diagnostic 
accuracy of these imaging techniques have used histology as the gold standard. There are, 
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however, substantial disadvantages to the continued use of histology for the diagnosis of 
adenomyosis. 
There remains significant disagreement as to the depth of infiltration required for the 
diagnostic criteria to be met. It has been suggested that units of microscopic fields should be 
used for this depth, however reported depths vary and include half a low-power field of view 
(Kurman 1994), one low-power field of view (Rosai 1989), one medium-power field of view 
(Gompel and Silverberg 1985) and one high-power field of view (Entmann 1988). 
Furthermore, there is significant variation in the size of microscopic fields when different 
microscopes are used (Ellis and Whitehead 1981) leading to the suggestion that a different 
measure should be used. The depth of infiltration as a proportion of the total uterine wall 
thickness has been proposed with depths greater than 25% (Ferenczy 1998) and greater than 
one third of the total thickness being used in the literature (Hendrickson & Kempson 1990), 
however uterine wall thickness is not uniform throughout the uterus, particularly in the 
presence of adenomyosis. Other studies have looked at specific depths of infiltration. 
Bergholt et al. re-examined hysterectomy specimens and applied differing depths of 
infiltration of endometrial glands into the myometrium (>1mm, >3mm & >5mm) for the 
diagnosis of adenomyosis and showed that the reported prevalence varied from 11.5%–18.2% 
(Bergholt et al. 2001).  Further variation was found depending on whether or not the presence 
of myometrial hyperplasia was used as a diagnostic criterion. This followed on from the 
study by Bird et al that showed that the reported prevalence of adenomyosis varied depending 
on the number of slices of histological tissue examined (Bird et al. 1972). 
Histopathological grading systems for severity of adenomyosis have been proposed. Bird & 
Molitor both used a histological system to grade the severity of adenomyosis based on depth 
of infiltration, whereby infiltration of endometrial tissue to the inner myometrium only was 
graded ‘slight’, infiltration to the middle third of the myometrium was termed ‘moderate’ and 
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infiltration to the outer third was termed ‘extensive’ (Bird et al. 1972; Molitor 1971) . Bird et 
al. also used a histological system to grade the degree of myometrial involvement. Here, 1-3 
endometrial glands per low-power field was graded ‘slight’, 4-9 endometrial glands per low-
power field was graded ‘moderate’ and 10 or more endometrial glands per low-power field 
was termed ‘marked’ (Bird et al. 1972). While these grading systems add an extra level of 
subtlety to the histological diagnosis of adenomyosis, they have not been prospectively 
evaluated, nor have their inter- and intra-observer variability been evaluated. 
This variation in diagnostic criteria in the histological diagnosis of adenomyosis poses 
problems not only in the diagnosis of the disease, but also in the investigation of the disease. 
Most studies looking at associations with the condition have compared the prevalence of the 
condition in different hysterectomized populations eg women with a history of menorrhagia 
and those without a history of menorrhagia, and then looked for statistical significance. 
Analysis and comparison of different studies is difficult when different diagnostic criteria are 
being used, making it difficult to draw firm conclusions about the condition when studied in 
this way. Even where standardised diagnostic criteria are used it has been suggested that 
awareness of the condition amongst individual pathologists could confer a further source of 
variance with the frequency of diagnosis of adenomyosis varying from 12-58% among 15 
different hospitals, and from 10-88% among 25 different histopathologists (Seidman and 
Kjerulff 1996). One explanation for this might be that histopathologists may see but not 
report adenomyosis unless specifically requested to do so, particularly if it is not relevant to 
the primary condition. This phenomenon may be exacerbated by the fact that once diagnosed 
post-hysterectomy, the condition has already been cured and so a diagnosis of adenomyosis 
will not influence future clinical management. This links to another fundamental problem 
with the use of histological examination of hysterectomy specimens to diagnose 
adenomyosis, which is that it precludes assessment of the success of conservative treatments 
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for the condition. This drawback of histological diagnosis does not apply to non-invasive 
diagnostic techniques, which must therefore be used for assessments of the effectiveness of 
conservative treatments for the condition. 
Finally, as histology remains the gold standard for diagnosis, much of our current knowledge 
of the condition comes from histological examination of the entire uterus. There is great 
national, international and temporal variation in the use of, and indications for, hysterectomy 
(Bergholt et al. 2001; Reid and Mukri 2005). Furthermore, populations of women undergoing 
hysterectomy in different regions are likely to be heterogenous and hence subject to 
significant demographic variation. All of these factors, directly linked to the use of histology 
as gold standard for diagnosis, explain both the significant variation in reported prevalences 
of adenomyosis, as well as the lack of consensus in the literature with regard to its clinical 
impact. 
 
2.6.1.3.2 Clinical 
There are no symptoms or symptom complexes that are pathognomic of adenomyosis and the 
symptoms classically ascribed to adenomyosis; abnormal uterine bleeding, painful periods 
and pelvic pain, are non-specific and associated with many other gynaecological pathologies. 
Furthermore, adenomyosis is often asymptomatic with 35% of women diagnosed with the 
condition in one study not having any symptoms explained by the disease (Benson and 
Sneedon 1958). Against this background, it is unsurprising that the accuracy of clinical 
diagnosis of adenomyosis is poor. In one study, a putative diagnosis of adenomyosis was 
confirmed in under half of women who subsequently underwent a hysterectomy (Lee et al. 
1984). 
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2.6.1.3.3 Ultrasound 
2.6.1.3.3.1 Diagnostic accuracy of ultrasound 
Many investigators have assessed the accuracy of transvaginal ultrasound in the diagnosis of 
adenomyosis, invariably in women undergoing hysterectomy, by comparing pre-operative 
ultrasound diagnosis with subsequent histological diagnosis. The reported sensitivity varies 
from 53%-89% and the reported specificity varies from 50%-99% (Dueholm 2006). The 
prevalence of adenomyosis in these studies varies widely which may reflect the differing 
histological criteria used, the different populations studied or the varying degree of patient 
selection involved. Generally, the more highly selected the patients are, the higher the 
sensitivity of diagnosis (Dueholm 2006). Large studies with no selection will, almost 
invariably, include women with either large uterine fibroids, or large numbers of fibroids. 
Fibroids of this nature are likely to prevent examination of the entire myometrium, meaning 
that ultrasound features of adenomyosis may be missed (Bazot et al. 2001). The difficulty in 
differentiating adenomyomas and fibroids may also lead to false positive diagnosis of 
adenomyosis. The presence of other pathologies might also reduce the accuracy of ultrasound 
in the diagnosis of adenomyosis. Studies of post-menopausal women, and even studies of 
pre-menopausal women if large enough, are likely to include some women with endometrial 
cancer. The presence of endometrial cancer, particularly if it involves the myometrium, 
makes the accurate diagnosis of adenomyosis much more challenging. 
 
2.6.1.3.3.2 Ultrasound features of adenomyosis 
Uterine enlargement in the absence of uterine fibroids and asymmetrical myometrial 
thickening are indirect signs of adenomyosis originally described on transabdominal 
ultrasound (Siedler et al. 1987; Bohlman et al. 1987). Transabdominal ultrasound, however, 
does not have sufficient resolution to be able to directly visualise some of the subtle 
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sonographic features of adenomyosis that have been described on transvaginal ultrasound 
(Bazot et al. 2002). The characteristic gross appearance and individual ultrasound features of 
adenomyosis on transvaginal ultrasound derive not only from the presence of endometrial 
glands and stroma within the myometrium, but also from the associated muscular 
hypertrophy and hyperplasia (Ferenczy 1998). Many of these features of adenomyosis are 
subtle and may be missed by those not trained to look for or recognise them. Some authors 
have suggested that the learning curve for those already familiar with TVUS to be able to 
diagnose adenomyosis can be up to 6 months (Dueholm 2006). These difficulties are 
compounded by the fact that the features of adenomyosis cannot always be seen on hard-copy 
images leading some authors to suggest that it must be diagnosed during real-time 
examination, which has implications for teaching (Reinhold et al. 1996). 
The asymmetrical myometrial thickening seen on transabdominal ultrasound can also be seen 
on TVUS. Another common feature described is heterogenous, poorly defined areas within 
the myometrium (Reinhold et al. 1995) or increased myometrial echotexture (Reinhold et al. 
1998). These may include or be accompanied by hyperechoic islands or anechoic myometrial 
cysts and lacunae (Fedele et al. 1992). Parallel shadowing can sometimes be seen distal to 
these myometrial features. Adenomyomas can be seen on TVUS but can be mistaken for 
uterine fibroids, with which they will often co-exist. It is particularly important to distinguish 
between the two in pre-operative imaging as adenomyomas are less amenable to surgical 
resection than uterine fibroids. Adenomyomas tend to be more elliptical than uterine fibroids 
and will be less well-circumscribed than uterine fibroids. They will also tend to have less 
calcification and less edge-shadowing (Reinhold et al. 1998). The use of Doppler can assist in 
distinguishing between adenomyomas and uterine fibroids. Blood flow around fibroids will 
be circumferential with minimal or absent blood flow seen within the fibroid, whereas with 
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adenomyomas, blood vessels will be seen following their normal course through the 
myometrium (Table 1). 
 
Table 1 – Ultrasound features of fibroids and adenomyomas that aid differentiation on TVUS. 
 Fibroid Adenomyomas 
Border definition Clear Poor 
Echogenicity Mixed with calcifications Hypoechoic with striate 
effect 
Shape Globular Elliptical 
Blood flow on Doppler 
imaging 
Circumferential Undisturbed 
 
Features seen closer to the endometrium include linear striations and an irregular or indistinct 
EMJ. Linear striations are seen as fine hyperechoic lines radiating from the endometrium into 
the myometrium. An irregular EMJ has been reported as a feature of adenomyosis on both B-
mode (Reinhold et al. 1998) and 3D imaging (Ahmed et al. 2007). Recently, Exacoustos et al. 
used the 3D coronal view of the uterus to visualise the EMJ and measure its thickness, to 
assess its usefulness in diagnosing adenomyosis (Exacoustos et al. 2011). They found that 
alterations in the EMJ had good diagnostic accuracy for diagnosing adenomyosis. While this 
is clearly an area of current research focus, there remain no published studies that describe a 
normal range for EMJ thickness, when measured in this way. 
A few studies have looked at which specific ultrasound features are the most accurate in the 
diagnosis of adenomyosis. Bazot et al. found that myometrial cysts were the most specific 
and sensitive criterion for diagnosing adenomyosis (Bazot et al. 2001). Kepkep et al. found 
that myometrial cysts, along with sub-endometrial linear striations and a regularly enlarged 
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globular uterus were the ultrasound features with the highest accuracy (74.3%, 71.4% and 
80% respectively). Sub-endometrial linear striations were the feature with the highest 
specificity (95.5%) (Kepkep et al. 2007). It should be noted that while there was considerable 
overlap in the ultrasound features used in these studies, the features used were not identical. 
 
2.6.1.3.4 MRI 
2.6.1.3.4.1 Diagnostic accuracy of MRI 
There are a small number of studies assessing the performance of MRI in the diagnosis of 
adenomyosis, all of which  included women undergoing hysterectomy. They compared pre-
operative MRI diagnosis with subsequent histological diagnosis and showed a sensitivity of 
70-86% and a specificity of 86-93% with a mean accuracy of 87.5% (Bazot et al. 2001, 
Reinhold et al. 1996, Dueholm et al. 2001). 
 
2.6.1.3.4.2 MRI features of adenomyosis 
The most widely used feature for diagnosing adenomyosis on MRI is increased JZ thickness. 
Focal or diffuse thickening (>12mm) of the JZ on T2-weighted images is considered highly 
suggestive of adenomyosis, whereas adenomyosis is unlikely to be present if the JZ is less 
than 8mm thick (Reinhold et al. 1998). Focal thickening is considered more specific than 
generalised thickening which must be differentiated from the appearance of thickening 
caused by physiological inner myometrial contractions. The timing of the MRI must also be 
considered before diagnosing adenomyosis by this criterion, as JZ thickness varies 
considerably during the menstrual cycle (Masui et al. 2001). The JZ is most clearly visible 
during the late secretory phase (Imaoka et al. 2003) and JZ thickness commonly appears to be 
>12mm during the menstrual phase, particularly on days 1 and 2. For this reason, some 
authors advocate avoiding MRI imaging during the menstrual phase of the menstrual cycle in 
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order to avoid false positive diagnosis of adenomyosis (Tamai et al. 2006). There are further 
limitations in using JZ thickness as the sole criterion to diagnose adenomyosis. One study 
found that the JZ was unmeasurable in almost a third of the women in their study, 22% of 
whom were subsequently diagnosed with adenomyosis on histology (Bazot et al. 2001).  
Less common MRI features of adenomyosis that have been reported include areas of low-
signal intensity within the myometrium with ill-defined borders (Reinhold et al. 1996) and 
islands of endometrial tissue visualised as punctate foci of high-signal intensity on T2-
weighted images. If cyclical bleeding occurs within these glands, they become cystic and will 
appear as areas of high-signal intensity on T-1 weighted imaging (Outwater et al. 1998). 
Rarely, endometrium can be seen to be invading the myometrium, which gives the 
appearance on MRI of ‘pseudowidening’ of the endometrium (Reinhold et al. 1999). While 
visualisation of these direct signs of adenomyosis has been reported, MRI has less-than-ideal 
sensitivity in detecting them, for example small myometrial cysts are only detected in 50% of 
cases. It has been suggested that this may be because MRI has insufficient spatial resolution 
to identify these smaller features of adenomyosis (Novellas et al. 2011). 
 
2.6.1.3.4.2 Comparison of diagnostic accuracy of MRI and TVUS 
Current opinion is divided as to which imaging modality should be the first-line diagnostic 
tool in adenomyosis. The diagnostic accuracies of TVUS and MRI have been compared in 
three studies of women undergoing hysterectomy for benign reasons (Table 2). While small 
advantages were found with MRI, pooled results show the two techniques to be equivalent 
and of intermediate accuracy (Dueholm 2006). A significant difference was found in the 
inter-observer variability of the two diagnostic modalities with MRI having good inter-
observer agreement (kappa value = 0.73) and TVUS having only fair inter-observer 
agreement (kappa value 0.38) (Dueholm et al. 2002). It may be that due to improvements in 
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the resolution of TVUS machines over the last decade, alongside better training in the 
ultrasound diagnosis of adenomyosis, the inter-observer agreement in the ultrasound 
diagnosis of adenomyosis is now better, but no published studies have reassessed the inter-
observer variability of TVUS in the diagnosis of adenomyosis.  
While TVUS, in the hands of experienced operators had comparable accuracy to MRI, MRI 
seemed to be a superior, less observer-dependent diagnostic tool in the diagnosis of 
adenomyosis. Nevertheless, a review concluded that where adenomyosis was suspected, 
TVUS should be the first-line diagnostic tool, with MRI reserved for cases where TVUS was 
inconclusive (Dueholm 2006). This conclusion may stem from the fact that TVUS is well-
tolerated (Bennett and Richards 2000) and is both cheaper and more easily accessible than 
MRI. 
 
Table 2 – Studies comparing the diagnostic accuracy of TVUS and MRI for the diagnosis of 
adenomyosis (Dueholm 2006). 
 Reinhold et al. 1996 
% (95% CI) 
Bazot et al. 2001 
% (95% CI) 
Dueholm et al. 2001 
% (95% CI) 
TVUS: 
Sensitivity 
Specificity 
PPV 
NPV 
 
89 (71-97) 
89 (80-95) 
71 (54-99) 
96 (89-99) 
 
65 (48-79) 
98 (90-100) 
93 (75-99) 
85 (75-91) 
 
74 (63-82) 
87 (81-91) 
68 (58-77) 
89 (84-92) 
MRI: 
Sensitivity 
Specificity 
PPV 
NPV 
 
86 (66-95) 
86 (76-92) 
65 (47-79) 
95 (87-98) 
 
78 (61-89) 
93 (84-97) 
84 (67-93) 
89 (80-95) 
 
78 (68-86) 
88 (83-92) 
70 (60-79) 
92 (87-95) 
 
 
2.6.1.3.5 CT 
There are limited data on the use of computerised tomography (CT) for the diagnosis of 
adenomyosis. A retrospective study of 16 women with an MRI diagnosis of adenomyosis, 6 
of whom had also had adenomyosis diagnosed on ultrasound scan, suggested that there were 
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features of adenomyosis that could be seen on CT scan, however the prospectively reported 
CT scans failed to diagnose adenomyosis in any of the women (Woodfield et al. 2009). 
 
2.3.1.3.6 Hysterosalpingography 
Adenomyosis has been diagnosed on hysterosalpingography, with features suggestive of 
adenomyosis including multiple small spicules with saccular endings (‘lollipop-like’ 
diverticula), extending from the endometrium into the myometrium (Wolf and Spataro 1988) 
and irregularity of the uterine contour with small outpouchings of contrast material (Simpson 
et al. 2006) (Figure 9). The diagnostic sensitivity is poor, however, and so 
hysterosalpingography is no longer used for the diagnosis of adenomyosis (Arnold et al. 
1995). 
 
Figure 9 - Hysterosalpingogram showing irregularity of the uterine contour with small 
outpouchings of contrast material. Findings consistent with diffuse adenomyosis (Simpson et 
al. 2006) 
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2.6.1.4 Clinical impact of adenomyosis 
2.6.1.4.1. Prevalence of adenomyosis 
The prevalence of adenomyosis in the general population remains unknown as, so far, it has 
only been possible to establish the diagnosis in pathological specimens, which confers a large 
selection bias. There is wide variation in the percentage of hysterectomy specimens found to 
have adenomyosis with reported prevalences of 5-70% (Azziz 1989). Explanations for this 
wide variation include the lack of consensus in the histological criteria used and variation in 
the number of tissue blocks examined.  
 
2.6.1.4.2 Symptoms of adenomyosis 
The exact clinical importance of adenomyosis remains uncertain (Dueholm 2006). The 
common symptoms said to be associated with adenomyosis are menorrhagia and 
dysmenorrhoea, with less commonly reported symptoms including chronic pelvic pain and 
dyspareunia. These symptoms are common to a number of other gynaecological conditions 
including uterine fibroids, endometrial polyps, endometrial hyperplasia and endometriosis. 
These conditions frequently co-existent, making assessment of causation of symptoms 
difficult. Furthermore, as is the case with endometrial polyps, fibroids and endometriosis, 
many women with adenomyosis are asymptomatic (Bird et al. 1972; Benson & Sneedon 
1958; Molitor 1971). 
 
2.6.1.4.2.1 Abnormal uterine bleeding 
The first detailed description of adenomyosis by Cullen over a century ago described a 
condition associated with ‘lengthened menstrual periods’ (Cullen 1908). Many investigators 
since then have looked for an association between adenomyosis and abnormal uterine 
bleeding with conflicting results. While many studies have found an association between the 
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two (Emge 1962; Bird et al. 1972; Benson and Sneedon 1958), many others have not 
(Bergholt et al. 2001; Parrazzini et al. 1997; Weiss et al. 2009). Despite the uncertainty 
regarding an association, adenomyosis is still considered an important cause of abnormal 
uterine bleeding as evidenced by its appearance in PALM-COEIN, a mnemonic created by 
FIGO in 2011 as an aide-memoire for causes of abnormal uterine bleeding (Figure 10) 
(Munro et al. 2011). 
 
Figure 10 – Illustration of PALM COEIN mnemonic for the causes of abnormal uterine 
bleeding (Munro et al. 2011). 
 
 
It is not only the association between adenomyosis and abnormal uterine bleeding that is 
uncertain. The mechanism by which adenomyosis might cause bleeding symptoms also 
remains unclear. The finding that mefenamic acid can reduce menstrual loss suggests that 
prostaglandins may play a role (Azziz 1989). Impaired contractility of the adenomyotic 
uterus has been suggested as another causative mechanism (Bergeron et al. 2006). Uterine 
enlargement secondary to adenomyosis might result in a larger endometrial surface area and 
therefore a greater volume of menstrual loss although a study by Rees et al. found no 
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correlation between measured menstrual blood loss and endometrial volume-to-surface ratio 
(Rees et al. 1984). 
 
2.6.1.4.2.2 Pain 
As with abnormal uterine bleeding, pain symptoms featured in early descriptions of 
adenomyosis. Cullen described a condition associated with ‘a great deal of pain’ (Cullen 
1908). Many authors have subsequently described an association between adenomyosis and 
pain symptoms, largely dysmenorrhoea (Emge 1962; Bird et al. 1972; Azziz 1989; Benson 
and Sneedon 1958), although once again, not all investigators have replicated these findings 
(Bergholt et al. 2001; Weiss et al. 2009). One prospective study found no difference in either 
frequency or severity of dysmenorrhoea or pelvic pain between 28 women with adenomyosis 
and 157 controls (Kilkku et al. 1984). Despite the lack of consensus as to the relationship 
between adenomyosis and pain, it is still considered a recognised cause of dysmenorrhoea 
(Peric and Fraser 2006). Dysmenorrhoea may be caused by uterine irritability and 
inflammation secondary to bleeding into foci of adenomyosis (Bergeron et al. 2006). 
 
2.6.1.4.2.3 Reproductive function  
Historically, adenomyosis has been considered a condition of parous women in their later 
reproductive years and so little work has focussed on its effect on reproductive function. 
Furthermore, an inability to diagnose the condition pre-hysterectomy has prevented 
investigation of the condition in a subfertile population. The advent of pre-operative 
diagnosis alongside an increase in maternal age has led to the condition being encountered 
more frequently in fertility clinics. Certainly, it is now accepted that the condition can be 
found in nulligravid and nulliparous women. Animal studies have suggested a deleterious 
effect on reproductive function with induced adenomyosis in baboons being associated with 
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lifelong infertility (Barrier et al. 2004). This has all contributed to an increasing focus on its 
role in reproductive function with some authors proposing that adenomyosis is a significant 
contributor to subfertility. As such, its diagnosis or exclusion should be mandatory in fertility 
investigations (Leyendecker et al. 2006). The prevalence of adenomyosis in a specific subset 
of fertility patients, women below the age of 36 with a confirmed diagnosis of endometriosis 
and fertile partners, was found to be as high as 90% (Kunz et al. 2005). It has been proposed 
that one mechanism through which adenomyosis might have a deleterious effect on fertility is 
through impairment of the inner myometrial contractions previously discussed as having a 
crucial role in sperm transport through the uterus (Leyendecker et al. 1996). The finding that 
adenomyosis has a negative impact on IVF/ICSI conception rates and live pregnancy rates 
(Salim et al. 2012; Tahlluri and Tremellen 2012) suggests that adenomyosis may negatively 
impact events after fertilisation and nidation as well. 
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2.6.2 Endometrial cancer 
2.6.2.1 Introduction  
Endometrial cancer was recently estimated to be the commonest gynaecological cancer in the 
developed world (Sankaranarayanan and Ferlay 2006). While the prognosis is good compared 
to other cancers, around 20% of women diagnosed with the condition will not survive beyond 
5 years. All but the earliest endometrial cancers, or those developing in foci of adenomyosis, 
will involve the EMJ. 
 
2.6.2.2 Prevalence 
In 2007, 7536 new endometrial cancers were diagnosed in the UK, making it the fourth 
commonest cancer in women (ONS 2009). It is classically, although not exclusively, a 
disease of post-menopausal women and its incidence is rising in this population, whereas it 
seems to be stable or decreasing in premenopausal or perimenopausal women (Bray et al. 
2005). This trend is likely to continue secondary to an ageing population, increasing obesity 
and a sharp fall in the number of hysterectomies being performed (Amant et al. 2005; 
Sorosky 2008; Reid and Mukri 2005). 
 
2.6.2.3 Clinical presentation 
Postmenopausal bleeding, defined as vaginal bleeding occurring at least a year after the last 
menstrual period, is the cardinal symptom of endometrial cancer. The probability of 
endometrial cancer in women presenting with postmenopausal bleeding is 5-10% (Amant et 
al. 2005). Prior to menopause, women with endometrial cancer may present with 
intermenstrual bleeding or irregular dysfunctional menstrual bleeding. Pain, vaginal 
discharge and pyometra are rarer symptoms and tend to be secondary to advanced cancer 
(Saso et al. 2011). 
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2.6.2.4 Risk factors for endometrial cancer 
The development of endometrial cancer has been observed to follow two distinct pathways 
(Bohkman 1983). Type I cancers, which account for 80-90%, are usually oestrogen-
dependent, endometrioid adenocarcinomas and generally have a good prognosis. Type II 
cancers are largely oestrogen-independent, have a variety of different histologies and tend to 
have a higher grade. Type II endometrial cancers therefore tend to have a worse prognosis as 
they tend to present later and behave more aggressively. As a significant majority of 
endometrial cancers are type I, most of the risk factors for the disease will link in some way 
to a relative increase in oestrogen exposure. A list of risk factors and protective factors can be 
seen in Table 3 (Saso et al. 2011). 
 
Table 3 – Risk factors and protective factors for endometrial cancer (Saso et al. 2011).   
Endogenous risk factors Increasing age 
Obesity and physical inactivity 
Early menarche and late menopause 
Low parity or infertility 
Polycystic ovarian syndrome 
Family history 
Lynch syndrome (hereditary non-polyposis 
colorectal cancer) 
Oestrogen secreting tumours (granulosa or 
thecal cell tumours of the ovary) 
Diabetes mellitus 
Hypertension 
History of breast cancer 
Immunodeficiency 
Exogenous risk factors Unopposed oestrogen-only hormone 
replacement therapy 
Tamoxifen therapy 
Previous radiotherapy 
Dietary factors 
Protective factors Cigarette smoking 
Combined oral contraceptive use for at least 
one year 
Grand multiparity 
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2.6.2.5 Precursor lesions for endometrial cancer 
Hyperoestrogenism is also a risk factor for endometrial hyperplasia, a premalignant condition 
that predisposes to endometrial cancer. Endometrial hyperplasia involves excessive cellular 
proliferation leading to an increased volume of endometrial tissue, with an increased ratio of 
endometrial glands to stroma (greater than 1:1). The WHO histological classification 
(Silverberg et al. 2003) is used in the UK. It classifies endometrial hyperplasia on the basis of 
the complexity of endometrial glands and the presence of any cytological atypia. Women 
with simple and complex endometrial hyperplasia have a risk of developing endometrial 
cancers of 1% and 3% respectively. Furthermore, 30-40% of women with complex atypical 
endometrial hyperplasia will have a concurrent adenocarcinoma, and those that do not, have a 
high risk of developing it (Mills and Longacre 2010) 
 
2.6.2.6 Diagnosis of endometrial cancer  
In the UK, if women report postmenopausal bleeding, they should be referred urgently to a 
gynaecological rapid-access clinic, where they should be seen within two weeks (NICE 
2005). A variety of different diagnostic tools have been evaluated in the investigation of 
women with suspected endometrial cancer. 
 
2.6.2.6.1 Blind endometrial biopsy 
Dilatation and curettage (D&C) used to be the most common method to acquire a sample of 
the endometrium for histological analysis. It has fallen out of favour for a variety of reasons, 
including its need to be performed under general anaesthetic, its cost, its low sensitivity in 
diagnosing intrauterine pathology (Bettocchi et al. 2001) and its relatively high complication 
rate. Where a blind endometrial endometrial biopsy is required, D&C has largely been 
superceded by outpatient endometrial sampling devices, modelled on the pipelle de cornier 
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prototype. Endometrial sampling with a pipelle can be performed in an office setting, without 
general anaesthetic, and often without local anaesthetic. A meta-analysis has shown that 
pipelle biopsy has a detection rate for endometrial cancer of 99.6% in postmenopausal 
women and 91% in premenopausal women. It had a sensitivity of 81% for the detection of 
endometrial hyperplasia (Dijkhuizen et al. 2000). It appears to be more accurate in 
symptomatic and post-menopausal women (Clark et al. 2001). For it to be cost-effective as 
the first-line diagnostic tool, the population in which it is used should have a prevalence of 
endometrial cancer of at least 15% (Dijkhuizen et al. 2003).  
  
2.6.2.6.2 Hysteroscopy 
Hysteroscopy involves the passage of a thin scope through the cervix, allowing direct 
visualisation of the uterine cavity and endometrium. It can be performed as a daycase 
procedure under general anaesthetic, but is increasingly being performed under local 
anaesthetic in an outpatient setting where it has been shown to have equivalent rates of 
patient satisfaction but a shorter recovery time (Kremer et al. 2000). The advantage of 
hysteroscopy over blind endometrial biopsy is that it allows targeted biopsying of suspicious 
areas. Even if the endometrial cavity appears normal, it is recommended that an endometrial 
biopsy be performed with one study finding that 50% of the endometrial cancers diagnosed 
on endometrial sampling, were not identified at hysteroscopy (Lo et al. 2000). A further 
advantage of hysteroscopy is that where endometrial polyps are present, a polypectomy can 
accurately be performed, thus treating a potential cause of abnormal bleeding, even if it 
subsequently turns out to be benign. 
Hysteroscopy under general anaesthetic has the same cost disadvantages as D&C, as well as 
being time-consuming for patients. While outpatient hysteroscopy has economic and clinical 
benefits it remains an invasive procedure associated with significant patient discomfort (Tahir 
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et al. 1999). Furthermore, it has a failure rate of up to 10% (Lo et al. 2000). In view of the 
invasive nature of outpatient hysteroscopy and its associated costs, transvaginal ultrasound 
has been recommended as the preferable first line investigation in women presenting with 
abnormal bleeding (Clark 2004). 
  
2.6.2.6.3 Transvaginal ultrasound 
In contrast to diagnostic hysteroscopy, TVUS is non-invasive, has no complications and is 
well-tolerated by women with postmenopausal bleeding (Nasri et al. 1991). It is therefore 
unsurprising that it has been extensively investigated as a tool for screening women with 
postmenopausal bleeding. 
 
2.6.2.6.3.1 Endometrial thickness 
In populations where the incidence of endometrial cancer is below 15%, using TVUS as the 
first line investigation, followed by endometrial biopsy if an abnormality is detected, has 
been shown to be more cost-effective than using endometrial biopsy as the first-line 
diagnostic tool (Dijkhuizen et al. 2003). In addition to saving money, using TVUS can 
potentially save women from undergoing invasive endometrial sampling. A meta-analysis of 
35 studies involving 5892 women that evaluated different thresholds to define abnormal 
endometrial thickening showed that a cut-off of 5mm had a sensitivity of 96% for 
endometrial cancer. Thus a postmenopausal woman presenting with vaginal bleeding with a 
pre-test probability of endometrial cancer of 10%, would have a 1% chance of endometrial 
cancer with a normal TVUS. The authors concluded that TVUS assessment of endometrial 
thickness could reliably identify women with a very low likelihood of endometrial cancer 
who could thus avoid endometrial sampling. While the sensitivity of this cut-off for 
diagnosing endometrial cancer is very high, the specificity was just 61% (Smith-Bindman et 
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al. 1998). Therefore the positive predictive value of endometrial thickness measurement in 
diagnosing endometrial cancer is poor and many women therefore undergo ultimately 
unnecessary invasive procedures. A subsequent meta-analysis had similar results and 
concluded that while TVUS assessment of endometrial thickness was a good test for ruling 
out endometrial cancer, it was not very good at ruling it in (Gupta et al. 2002). TVUS remains 
the standard first-line test in the diagnosis of endometrial cancer, however because of the 
limitations of using endometrial thickness alone, many investigators have looked at ways to 
improve its specificity. 
 
2.6.2.6.3.2 Endometrial thickness and morphology 
Various endometrial ultrasound criteria have been assessed in attempts to improve the 
specificity of ultrasound in diagnosing endometrial cancer, with mixed results. While some 
have found assessments of endometrial and EMJ morphology useful in differentiating benign 
and malignant endometria (Randelzhofer et al. 2002; Epstein and Valentin 2006), others have 
not (Epstein et al. 2001; Epstein et al. 2002). 
 
2.6.2.6.3.3 Transvaginal ultrasound with Doppler 
There have been similarly contrasting results from studies assessing the use of Doppler to 
improve the accuracy of ultrasound in diagnosing endometrial cancer. An early study 
reported promising results in the use of colour Doppler to aid diagnosis of endometrial cancer 
(Bourne et al. 1991). Subsequent studies of colour Doppler flow in both the uterine and 
endometrial arteries were however, unable to show that it was useful in discriminating 
between benign and malignant endometrial lesions (Sladkevicius et al. 1994; Sheth et al. 
1995). The evidence is no more consistent when Doppler has been used to assess the 
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morphology of endometrial vasculature. Alcazar et al. reported that a particular power 
Doppler pattern of vasculature could be observed in more than 80% of cases of endometrial 
cancer (Alcazar et al. 2003). Other investigators used an algorithm including power Doppler 
assessment of endometrial vascularity to estimate the risk of endometrial malignancy. While 
they concluded that their algorithm was better than subjective assessment, at differentiating 
benign and malignant endometria in women with an endometrial thickness of 5-15mm, this 
conclusion did not reach statistical significance (Epstein et al. 2002). Subsequent work by the 
same research group was unable to show that using colour Doppler to assess the number of 
blood vessels within the endometrium aided the diagnosis of endometrial cancer in women 
with postmenopausal bleeding (Epstein and Valentin 2006) 
 
2.6.2.6.3.4 Three-dimensional ultrasound assessment of endometrial volume  
Gruboeck et al. used compared endometrial thickness and endometrial volume measured by 
3D ultrasound in the assessment of women with postmenopausal bleeding (Gruboeck et al. 
1996). They found that endometrial volume assessment was a better screening tool than 
endometrial thickness measurement with an endometrial volume of 13mls having a 
sensitivity of 100% and a specificity of 99.8% for the diagnosis of endometrial cancer. A 
subsequent study again showed a higher sensitivity for endometrial volume than endometrial 
thickness (Mansour et al. 2007) although interestingly their cut-off value for endometrial 
volume was significantly different to that proposed in the study by Gruboeck et al. 
Furthermore, they used D&C as their gold standard which has been shown to be unreliable 
(Grimes 1982). Perhaps what is most noteworthy is that despite the early promise of 3D 
endometrial volume measurement in the screening of women with postmenopausal bleeding, 
a relatively small number of papers have subsequently been published on the subject. A 
recent review article (Alcazar and Jurado 2011) suggested that most of the published studies 
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showed that endometrial volume was superior to endometrial thickness. One study 
(Opolskiene and Valentin 2010) showed no advantage with 3D endometrial volume 
measurement. 
 
2.6.2.7 Staging 
Staging of endometrial cancer can be based on surgical, clinical, radiological of 
histopathological criteria, however surgical staging has been shown to have better prognostic 
value (Creasman et al. 2006). This led to FIGO updating the staging of endometrial cancer to 
more accurately reflect stage-for-stage prognosis (Table 4) (Creasman 2009). About 80% of 
women present with stage I disease and can be treated with hysterectomy and bilateral 
salpingo-oophorectomy. 
 
Table 4 – Revised FIGO staging of endometrial cancer (Creasman et al. 2009). 
Stage Ia 
Stage Ib 
<50% myometrial invasion 
>50% myometrial invasion 
Stage II Tumour confined to the uterine corpus but involving cervical 
stroma 
Stage IIIa 
Stage IIIb 
Stage IIIc 
Tumour invading the serosa of the uterine corpus and/or adnexa 
Vaginal or parametrial involvement 
Metastasis to pelvic or para-aortic lymph nodes 
Stage IVa 
Stage IVb 
Invasion of bladder and/or bowel mucosa 
Distant metastases including intra-abdominal and/or inguinal 
lymph nodes 
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3.0 Conclusion to Background 
It is clear that there is an increasing focus on the EMJ and what its role in various pathologies 
might be. Gynaecologists and ultrasonographers are able to look at this area of the uterus in 
greater detail and depth and are even starting to make clinical decisions based on their 
assessments. Yet there is a danger that the clinical decision-making is out of step with what 
we know about the EMJ and its appearance on ultrasound. Obvious issues worth investigating 
are whether ultrasound assessment of the EMJ is reproducible and what clinical and 
demographic factors influence the appearance of the EMJ. 
Adenomyosis, a disease of the EMJ, has been studied for considerably longer than the EMJ 
itself and yet still so many aspects of the disease remains unclear or uncertain. While 
histology has historically been the primary diagnostic tool for investigating adenomyosis, the 
significant reduction in the number of hysterectomies now being performed for benign 
disease has blunted its usefulness in investigating the disease. Almost all ultrasound studies 
of adenomyosis to date have assessed its diagnostic accuracy. While these studies have 
shown that transvaginal ultrasound has good accuracy in diagnosing adenomyosis, few if any 
ultrasound studies have attempted to investigate some of the many clinical uncertainties that 
remain about the disease. This has perhaps been due to concerns about the reproducibility of 
ultrasound diagnosis of adenomyosis. Significant uncertainties remain about the most basic 
aspects of the disease including its prevalence and even whether or not it has any clinical 
significance. Ultrasound should now be used to investigate these questions. 
The role of ultrasound in the screening of women with post-menopausal bleeding is more 
established. Transvaginal ultrasound assessment of endometrial thickness remains the 
primary determinant of which women can be safely reassured and which women need 
endometrial sampling. Using ultrasound in this way has a high sensitivity for endometrial 
cancer but a low specificity meaning that many women undergo ultimately unnecessary 
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invasive investigations. Several investigators have looked at whether more sophisticated 
transvaginal ultrasound assessment of these women might be able to improve the diagnostic 
accuracy of ultrasound and assessment of the EMJ has been suggested as one aspect of the 
ultrasound examination that may aid this. 
Given the above, I feel that the aims of this thesis should be to examine the reproducibility of 
ultrasound assessment of the EMJ and investigate what factors affect it visualisation, examine 
the reproducibility of ultrasound diagnosis of adenomyosis, determine the prevalence of 
ultrasound features of adenomyosis in women attending a general gynaecology clinic and 
investigate whether their presence is associated with clinical symptoms and lastly, determine 
whether assessment of the EMJ can increase the diagnostic accuracy of ultrasound in the 
investigation of women with post-menopausal bleeding 
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PART II MATERIALS AND METHODS 
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1.0 MATERIALS AND METHODS 
1.1 Setting 
1.1.1 The Gynaecological Diagnostic and Treatment Unit, University College Hospital 
The work contained in this thesis was carried out in the Gynaecology Diagnostic and 
Outpatient Treatment Unit (GDOTU) of University College Hospital between October 2008 
and March 2011. Situated in central London, University College Hospital is a teaching 
hospital and tertiary referral centre which primarily serves the needs of the people of Camden 
and Islington. The trust has an annual turnover of more than £769 million, employs over 6000 
staff and has 665 inpatient beds. It sees over 789,000 outpatients a year and has around 
125,000 inpatient admissions a year. The hospital was formed in 1994 and became an NHS 
foundation Trust in 2004. The Women’s Health department at UCH offers specialist 
gynaecology services including gynaecological ultrasound scanning, early pregnancy care, 
ambulatory gynaecology, urogynaecology, colposcopy, menopause, gynaecological 
oncology, paediatric gynaecology, a specialist endometriosis centre, an assisted conception 
unit and a specialist clinic for African women. In the financial year 2009/10, there were 
11,270 patient attendances at the GDOTU of which 6,487 were women with early pregnancy 
problems and 4,783 of which were non-pregnant women with gynaecological problems. 
 
1.2 Ultrasound 
1.2.1 Two-dimensional transvaginal ultrasound 
In this thesis, all the ultrasound scans were performed by trained gynaecologists on a Voluson 
E8 ultrasound machine (GE Medical Systems, Milwaukee, WI, USA) using a 4-9 MHz probe 
with three dimensional facility. The scans were all perfomed in lithotomy position using a 
standardised protocol. First the uterus was examined in the transverse plane to identify the 
cervical canal and the uterine cavity. The probe was then rotated 90
o
 anti–clockwise and the 
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uterus and endometrium were visualised in the longitudinal plane. Care was taken to identify 
the point at which the endometrial thickness was greatest before measuring it in millimetres. 
If free fluid was present in the endometrial cavity, the fluid was measured separately and 
subtracted from the total thickness (Lee et al. 2005). Fibroids were diagnosed based on direct 
visualisation using previously described diagnostic criteria (Anderson 1999). Adenomyosis 
was diagnosed if any of the following ultrasound features of adenomyosis were present: 
asymmetrical myometrial thickening, myometrial cysts, linear striations, parallel shadowing, 
adenomyomas, hyperechoic islands and an irregular EMJ on either B-mode or 3-dimensional 
imaging (Table 5, Figures 11-17) (Naftalin et al. 2012b). Previously published ultrasound 
features of adenomyosis that were not used to diagnose adenomyosis in this thesis include a 
heterogenous myometrial echotexture and a globular uterine configuration. These were both 
excluded as they had been found to have a low positive predictive value (Bazot et al. 2001). 
The JZ measurements taken from 3D coronal views of the uterus proposed by Exacoustos et 
al. were not used as they were published after our study had started. Even so we would not 
have included them as their accuracy has yet to be prospectively assessed. Endometrial 
polyps were diagnosed based on direct visualisation using previously described criteria 
(Timmerman et al. 2003). The examination was then concluded by examining both adnexa 
and the pouch of Douglas, identifying both ovaries and any endometriotic nodules where 
possible. 
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Table 5 – Ultrasound features of adenomyosis used in this thesis (Naftalin et al. 2012b). 
Asymmetrical myometrial thickening 
Parallel shadowing 
Linear striations 
Myometrial cysts 
Hyperechoic islands 
Adenomyomas 
Irregular EMJ 
 
 
Figure 11 - Asymmetrical myometrial thickening. A longitudinal view of an anteverted uterus 
in which the distance from the endometrium to the anterior serosal surface (thick white line) 
is much greater than the distance from the endometrium to the posterior serosal surface (thin 
white line) (Naftalin et al. 2012b) 
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Figure 12 - Parallel shadowing. A longitudinal view of a retroverted uterus in which parallel 
hypoechoic lines can be seen running through the anterior myometrium (yellow s) (Naftalin 
et al. 2012b) 
 
Figure 13 - Linear striations. A transverse view of the uterus showing a linear striation seen 
as thin hyperechoic lines (thin white arrow) extending from the endometrium into the 
myometrium (Naftalin et al. 2012b) 
 
 
 
s s 
s 
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Figure 14 - Myometrial cysts. A transverse view of the uterus showing several myometrial 
cysts (thin white arrows) seen as anechoic lesions within the myometrium (Naftalin et al. 
2012b) 
 
Figure 15 - Hyperechoic islands. A coronal view of a uterus where hyperechoic islands of 
tissue are seen in the fundal and lateral portions of the myometrium (thin white arrows). 
(Naftalin et al. 2012b) 
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Figure 16 - Adenomyomas. A longitudinal view of a retroverted uterus showing an 
adenomyoma in the anterior myometrium (between white arrows). (Naftalin et al. 2012b) 
 
Figure 17 -  Irregular endometrial-myometrial junction. A coronal view of a uterus with an 
irregular endometrial-myometrial junction. (Naftalin et al. 2012b) 
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An ultrasound diagnosis of endometriosis was made if ovarian endometriomas or 
endometriotic nodules were visualised on ultrasound scan. Ovarian cysts were classified as 
endometriomas when they appeared as well-circumscribed thick-walled cysts that contained 
homogeneous low-level internal echoes (‘ground glass’) (Tailor et al. 1999). Endometriotic 
nodules were typically visualised as stellate hypoechoic or isoechogenic solid masses with 
irregular outer margins (Bazot et al. 2007) which were tender on palpation and fixed to the 
surrounding pelvic structures. 
 
1.2.2 Three-dimensional transvaginal ultrasound 
All 3-D ultrasound volume acquisitions were performed immediately after the 2D TVUS by 
the same operator. The volume acquisition technique was performed in a standardised fashion 
using a maximum sweep angle of 120 degrees and the medium quality setting. The uterus 
was visualised in the longitudinal plane with the angle of the ultrasound beam and the axis of 
the endometrial cavity approaching 90 degrees. In order to minimise artefacts, the depth of 
the acquired volume was adjusted to cover the entire uterus with minimal inclusion of 
parametrial structures. The volumes were generated by automatic rotation of the mechanical 
transducer through 360
o
. The probe was held steady and the patients were asked to hold their 
breath whilst volume acquisition was switched on. Following acquisition, the rendered 
volumes were saved to the hard drive of the machine for analysis. 
 
1.2.2.1 Off-line assessment of uterine volumes 
Assessment of 3D uterine volumes was performed offline. A coronal view was obtained 
using render mode, by placing a straight or curved line along the endometrial stripe on the 
sagittal and transverse views (Panel A and B of the multi-planar view). The multi-planar view 
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was then adjusted until a satisfactory coronal image was obtained of both the endometrial 
cavity and the external uterine contour, with visualisation of both interstitial portions of the 
fallopian tube. The gradient light and sepia settings were used to optimise the view of the 
EMJ, which was visualised as a hypoechoic area surrounding the endometrial cavity.  
When using off-line evaluation of stored uterine volumes to diagnose adenomyosis, a detailed 
assessment of the entire myometrium was performed looking for the presence of each 
individual ultrasound feature of adenomyosis. Both operators were required to manipulate the 
rendered views, in whichever way they wanted, until they had visualised the entire 
myometrium and a diagnosis was reached.  
 
 
1.3 Pictorial Blood Loss Assessment Charts 
Pictorial Blood Loss Assessment charts (PBACs) were given to premenopausal women to 
complete in order to obtain semi—quantitative information about the amount of menstrual 
loss they had each cycle. PBACs use a scoring system to calculate total menstrual loss that 
accounts for both the number of sanitary towels or tampons a woman uses during her period 
and also the degree to which each item is soiled (Figure 18). A pictorial chart score of  >100, 
when used as a diagnostic test for menorrhagia, has been shown to have a high specificity and 
sensitivity (Higham et al. 1990). 
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Figure 18 – A Pictorial blood loss analysis chart. 
 
 
1.4 Numerical Rating Scale (NRS) 
Premenopausal women were asked to complete an 11-point Numerical Rating Scale (NRS) 
(Figure 19) in order to obtain a subjective assessment of how painful they found their periods. 
The NRS is a scale where the extremes are no pain and pain as bad as it could be and patients 
are asked to put a mark on the scale to represent the intensity of the pain being measured. 
 
Figure 19 – An 11-point numerical rating scale. 
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Women were given the scale and asked to put a mark on the scale to represent the intensity of 
the worst pain they experienced with their last period. NRSs have been shown to be sensitive 
(Jensen et al. 1986), simple to use with a low failure rate (Van Tubergen et al. 2002) and are 
considered to be preferable to traditional visual analog scales for assessment of pain intensity 
(Mannion 2007). They have been shown to have sufficient reliability and validity to be used 
in clinical research (Lara-Munoz et al. 2004).  
 
1.5 Endometrial sampling (Pipelle & Hysteroscopy) 
In women with postmenopausal bleeding found to have an endometrial thickness on TVUS of 
>5mm, endometrial sampling was performed. If the endometrium was globally thickened, 
and the woman was able to tolerate outpatient endometrial sampling, a pipelle de cornier was 
used (Prodimed, Neuillyen-Thelle, France). Women with a focally thickened endometrium 
were referred for either outpatient or day-case hysteroscopy.  
 
1.6 Statistical analysis 
Data were collected and stored in electronic databases (Microsoft Excel 2003). The Statistical 
Package for Social Sciences version 15.0 (Statistical Analysis Systems, Chicago, Illinois) was 
used to analyse data. Details of individual tests are documented in the relevant chapters. The 
level of statistical significance was chosen as p<0.05. 
 
1.7 Ethical committee approval 
The Local Research and Ethics Committee of University College Hospital granted approval 
for all studies undertaken. They advised that none of the studies required full formal ethical 
approval. 
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III Results 
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[1] INTER- AND INTRAOBSERVER VARIABILITY IN THREE-DIMENSIONAL 
ULTRASOUND ASSESSMENT OF THE ENDOMETRIAL-MYOMETRIAL 
JUNCTION 
  
1.1 BACKGROUND 
The endometrial-myometrial junction (EMJ) is thought to play an important role in both 
physiological and pathophysiological processes within the uterus. It has been suggested that a 
careful ultrasound examination of the EMJ junction can yield clinically useful information in 
a number of different pathologies and so should become part of the routine ultrasound 
examination of the uterus (Naftalin and Jurkovic 2009).  
In order to obtain clear images of the EMJ, particularly at the lateral and fundal aspects of the 
uterine cavity, high resolution ultrasound equipment with 3D imaging facilities is often 
required, which has only become available in recent years. There are a small number of 
published studies involving assessment of 3D views of the EMJ
 
(Exacoustos et al. 2011; 
Alcazar et al. 2009), however little is known about the reproducibility of 3D ultrasound 
assessment of the EMJ. The aim of this study was to examine inter- and intra-observer 
reproducibility of 3D ultrasound visualisation of the EMJ. 
 
1.2 METHODS 
Inter- and intraobserver variability in 3D ultrasound assessment of the EMJ was tested on a 
group of 30 women. Real time ultrasound examinations were performed and 3D volumes 
were obtained in the manner described in the materials and methods section. The investigator 
who performed the ultrasound examinations (Dr Will Hoo) was a specialist in gynaecological 
ultrasound with a special interest in benign gynaecological conditions. We included in the 
study only non-pregnant women with a normal uterus on ultrasound scan. After selecting the 
volumes for the study he did not participate in further reproducibility analysis. All saved 
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volumes were then examined independently by two other investigators (Mr Davor Jurkovic 
and Dr Joel Naftalin) who were blinded to each other’s findings. The volumes were examined 
using planar reformatted sections and volume rendering. The quality of visualisation of the 
EMJ was graded as follows: 1.) Optimal – The EMJ was clearly visible and could be 
examined in its entirety, 2.) Satisfactory – Most, but not all parts of the EMJ could be clearly 
visualised, 3.) Unsatisfactory – Large parts of the EMJ could not be clearly visualised (Figs 
20-22). It was considered that EMJ’s graded as unsatisfactory were inadequate for clinical 
evaluation, whereas 1) & 2) could be used for clinical evaluation.  
 
1.3 STATISTICAL ANALYSIS 
Statistical analysis was performed, using SPSS software (SPSS Inc., Chicago IL). The inter-
observer and intra-observer agreement for the classification of EMJ visualisation was 
assessed by calculating the kappa statistic. 
 
1.4 RESULTS 
There was complete agreement between the two operators in classifying the visualisation of 
the EMJ as being optimal or not. Both operators classified 16 EMJs as optimal, 8 as 
satisfactory and 2 as unsatisfactory. There was a discrepancy between the two observers in 4 
cases. In two of these, operator 1 classified two cases as satisfactory which operator 2 had 
described as unsatisfactory. In the other two cases, the reverse occurred. The inter-observer 
agreement was good with a kappa value of 0.77 (Table 6). The intra-observer agreement was 
excellent for observer 1 with a kappa value of 0.83 (Table 7) and good for observer 2 with a 
kappa value of 0.70 (Table 8). 
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Figure 20 - Coronal view of uterus with EMJ visualisation classified as optimal (Naftalin et 
al. 2012a) 
 
 
Figure 21 - Coronal view of uterus with EMJ visualisation classified as satisfactory (Naftalin 
et al. 2012a) 
 
 
Figure 22 - Coronal view of uterus with EMJ visualisation classified as unsatisfactory 
(Naftalin et al. 2012a) 
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Table 6 - Inter-observer variability in the assessment of visualisation of the EMJ (Naftalin et 
al. 2012a) 
 Operator 2 
Operator 
1  
 Optimal Satisfactory Unsatisfactory Total 
Optimal 16 0 0 16 
Satisfactory 0 8 2 10 
Unsatisfactory 0 2 2 4 
Total 16 10 4 30 
k=0.77 (good agreement) 
95%CI (0.58 – 0.96) 
Standard error of kappa = 0.097 
 
Table 7 - Intra-observer variability (Operator 1) in the assessment of visualisation of the EMJ 
(Naftalin et al. 2012a) 
 Operator 1 (2
nd
 assessment) 
Operator 1 
(1
st
 
assessment) 
 Optimal Satisfactory Unsatisfactory Total 
Optimal 15 1 0 16 
Satisfactory 0 9 1 10 
Unsatisfactory 0 1 3 4 
Total 15 11 4 30 
k=0.83 (excellent agreement) 
95%CI (0.66 – 1) 
Standard error of kappa = 0.090 
 
 
Table 8 - Intra-observer variability (Operator 2) in the assessment of visualisation of the EMJ 
(Naftalin et al. 2012a) 
 Operator 2 (2
nd
 assessment) 
Operator 2 
(1st 
assessment) 
 Optimal Satisfactory Unsatisfactory Total 
Optimal 16 0 0 16 
Satisfactory 3 7 0 10 
Unsatisfactory 0 2 2 4 
Total 19 9 2 30 
k=0.70 (good agreement) 
95%CI (0.47 – 0.93) 
Standard error of kappa = 0.117 
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[2] FACTORS AFFECTING VISUALISATION OF THE EMJ ON THREE-
DIMENSIONAL ULTRASOUND 
 
2.1 BACKGROUND 
The EMJ is thought to play an important role in both physiological and pathophysiological 
processes within the uterus. Its appearance on ultrasound is known to be altered in the 
presence of certain pathologies, for example adenomyosis (Naftalin and Jurkovic 2009) and 
invasive endometrial cancer (Randelzhofer et al. 2002). It is not known, however, whether 
physiological factors affect its ultrasound appearance. The aim of this study was to identify 
demographic and physiological factors which might affect the quality of visualisation of the 
EMJ on 3D ultrasound. 
 
2.2 METHODS 
This was a prospective observational study of women attending our gynaecology clinic. In all 
women, indication for the scan, age, parity, date of the last menstrual period, menstrual 
pattern and the use of exogenous hormones was recorded and stored on a dedicated database 
(PIA Fetal Database, version 5.5.4.152, Viewpoint Bildverarbeitung GmbH, Munich, 
Germany). Postmenopausal status was defined as the absence of menstruation for ≥ 12 
months in women ≥ 40 years old. Ultrasound examinations were performed in the manner 
described in the materials and methods section. The examination was then concluded by 
examining the adnexa and identifying both ovaries. The presence of a corpus luteum was 
determined on B-mode and Doppler examination. Premenopausal women with regular 
menstrual cycles, whose ovaries contained a corpus luteum were classified as being in the 
luteal phase of the cycle, and the remaining women with regular menstrual cycles were 
classified as being in the proliferative phase of the cycle. 
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We included in the study only women with a normal uterus on ultrasound scan. Those with 
evidence of any myometrial or endometrial pathology, pregnant women and those in whom 
the ovaries could not be seen clearly were excluded. Various demographic and physiological 
variables were recorded and we analysed their effect on the quality of EMJ visualisation on 
3D volume rendering. 
 
2.3 STATISTICAL ANALYSIS 
Statistical analysis was performed, using SPSS software (SPSS Inc., Chicago IL). 
Spearman’s rank correlation was used to examine the association of EMJ visualisation with 
age, parity and endometrial thickness. The Kruskal-Wallis test was used to examine the 
association between EMJ visualisation and the stage of menstrual cycle and the Mann-
Whitney test was used to examine the association between EMJ visualisation and menopausal 
status.  Subsequently, the joint effect of the various factors upon EMJ visualisation was 
examined in a multivariable analysis. As EMJ visualisation was measured using an ordinal 
scale, the analysis was performed using ordinal logistic regression. 
 
2.4 RESULTS 
413 consecutive, non-pregnant women were examined by a single operator (JN). 312 women 
(75.5%) were excluded due to the presence of uterine pathology and the remaining 101 
(24.5%) were included in data analysis. The principal indications for ultrasound examination 
for the women included in data analysis are presented in Table 9. In 47/101 (46.5%) of the 
women, visualisation of the EMJ was classified as optimal, in 42/101 (41.6%) as satisfactory 
and in 12/101 (11.9%) as unsatisfactory. Spearman’s rank correlation showed that the ability 
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to visualise the EMJ was significantly affected by a women’s age, parity, and endometrial 
thickness as measured by ultrasound scan (Table 10). 
 
The Kruskal-Wallis test did not show a significant effect of the stage of the menstrual cycle 
or menopausal status on the quality of EMJ visualisation (Table 11). A subsequent analysis 
assessing menopausal status only, using the Mann-Whitney test, showed a significant 
association between menopausal status and EMJ visualisation (Table 12). 
 
The joint effect of the various factors on EMJ visualisation was examined in a multivariable 
analysis. A backwards selection procedure was used to retain only the statistically significant 
variables. The results indicated that only parity and endometrial thickness were significantly 
associated with EMJ visualisation. After adjusting for the effects of these two variables, there 
was no significant difference in EMJ visualisation between pre and post-menopausal women 
and the previously noted association between age and EMJ visualisation was no longer found 
to be significant.  
 
The size of effect of each variable upon EMJ visualisation, in the form of odds ratios, can be 
seen in Table 13. These indicate the odds of being in the next best visualisation category 
(optimal visualisation rather than satisfactory visualisation, or satisfactory visualisation rather 
than unsatisfactory visualisation) for an increase in parity of one, or a 5mm increase in 
endometrial thickness. The results suggest that increasing parity is negatively associated with 
EMJ visualisation, whereby for each additional child delivered, the odds of being in the next 
best visualisation category were almost halved. The results for endometrial thickness suggest 
that increasing endometrial thickness is associated with better EMJ visualisation, a 5-mm 
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increase in endometrial thickness being associated with a three-fold increased risk of being in 
next best visualisation category. 
 
Table 9 - Principal indications for examination (Naftalin et al. 2012a) 
Principal indication for examination n (%) 
Pelvic pain/dyspareunia 
Subfertility 
Irregular/Intermenstrual bleeding 
Heavy or painful menstrual bleeding 
Amenorrhoea 
Postmenopausal bleeding 
Suspected ovarian cyst 
Postcoital bleeding 
Other 
31 
22 
11 
10 
7 
7 
5 
2 
6 
 
Table 10 – Result of Spearman’s rank correlation in assessing the effect of age, parity and 
endometrial thickness on EMJ visualisation (Naftalin et al. 2012a) 
Variable EMJ Category Median (IQR) Correlation 
Coefficient 
P-value 
     
Age Optimal 32 (27, 36) 0.30   0.006 
 Satisfactory 32 (27, 42)   
 Unsatisfactory 46 (39, 60)   
     
Parity Optimal 0 (0, 0) 0.33 <0.001 
 Satisfactory 0 (0, 1)   
 Unsatisfactory 1.5 (0.5, 3.5)   
     
Endometrial Optimal 6.3 (3.5, 9.5) -0.36  <0.001 
Thickness Satisfactory 3.5 (2.5, 6.0)   
 Unsatisfactory 3.1 (1.9, 4.9)   
     
 
Table 11 – Result of Kruskal-Wallis test in assessing the effect of stage of menstrual cycle on 
EMJ visualisation (Naftalin et al. 2012a) 
Stage of cycle Optimal 
n (%) 
Satisfactory 
n (%) 
Unsatisfactory 
n (%) 
P-value 
     
Proliferative 19 (46%) 20 (49%) 2 (5%) 0.08 
Secretory 11 (58%) 5 (26%) 3 (16%)  
Irregular / absent 10 (63%) 3 (19%) 3 (19%)  
Post-menopausal 2 (14%) 8 (57%) 4 (29%)  
Combined pill 5 (45%) 6 (55%) 0 (0%)  
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Table 12 – Result of Mann-Whitney test in assessing the effect of menopausal status on EMJ 
visualisation (Naftalin et al. 2012a) 
Menopausal 
status 
Optimal 
n (%) 
Satisfactory 
n (%) 
Unsatisfactory 
n (%) 
P-value 
     
Pre-menopausal 45 (52%) 34 (39%) 8 (9%)   0.004 
Post-menopausal 2 (14%) 8 (57%) 4 (29%)  
     
 
Table 13 – Results of multivariable analysis assessing the joint effect of the various factors 
on EMJ visualisation (Naftalin et al. 2012a) 
Variable Odds Ratio (95% CI) P-value 
   
Parity 0.53 (0.36, 0.78) 0.001 
Endometrial Thickness 
(*)
 3.00 (1.52, 5.88) 0.001 
   
(*) Odds ratio given for a 5mm increase in endometrial thickness 
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[3] INTER- AND INTRAOBSERVER VARIABILITY IN THE ULTRASOUND 
DIAGNOSIS OF ADENOMYOSIS USING STORED 3D VOLUMES 
 
3.1 BACKGROUND 
The ability to diagnose adenomyosis without having to perform a hysterectomy has helped 
our understanding of the disease. There remains controversy, however, as to which imaging 
modality should be the first-line diagnostic tool. Ultrasound is relatively cheap, widely-
accessible and well-tolerated and has been shown to have comparable accuracy to MRI in the 
diagnosis of adenomyosis (Dueholm 2006). However, it was found to have a significantly 
lower inter-observer variability (kappa=0.38) than MRI (kappa= 0.73) in the only published 
study to compare reproducibility of diagnosis in the two modalities (Dueholm et al. 2002). 
Furthermore, some authors have claimed that, unlike MRI, the ultrasound diagnosis of 
adenomyosis can only be made during a real-time scan, as the ultrasound features of 
adenomyosis cannot be reliably identified from static images (Reinhold 1999). The aim of 
this study was to assess the inter- and intra-observer variability in ultrasound assessment of 
adenomyosis using stored 3D uterine volumes. This assessment included diagnosis of 
adenomyosis, the number of ultrasound features of adenomyosis seen and a subjective 
assessment of severity of disease. The comparisons were made between: 
a) real-time ultrasound scans and evaluation of the uterus from a stored 3D uterine 
volume (same operator performing scan and stored volume assessment but 3 years 
apart) 
b) two different operators evaluating the same stored uterine volumes 
c) the same operator evaluating the same stored uterine volumes on two separate 
occasions 
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3.2 METHODS 
Out of a total of 985 archived 3D uterine volumes taken from women consecutively scanned 
women between January 2009 and January 2010 by the same operator, 36 were selected by 
one of the investigators (Dr Kate Pateman) for the examination of reproducibility of 
ultrasound diagnosis of adenomyosis. The volumes were selected to ensure a good case mix 
including normal uteri and those with adenomyosis. Those with adenomyosis were selected 
to ensure a wide range in both the number and type of ultrasound feature of adenomyosis. 
Volumes were not selected if it were not possible to adequately assess the entire 
myometrium.  Reasons for this included the presence of an IUCD, multiple large fibroids and 
poor quality of stored volumes. The reproducibility assessments were performed more than 3 
years after the original real-time scans in order to minimise bias in the assessment of intra-
observer agreement between diagnosis on real-time ultrasound and on assessment of stored 
3D uterine volumes. The first and second assessment of 3D stored uterine volumes (both 
assessments by Dr Joel Naftalin) were performed two weeks apart, and in a different order 
from the first assessment, (the order being selected by Dr Kate Pateman who played no 
further part in ultrasound assessment), again, in order to reduce bias. A third assessment of 
the stored volumes was then performed by a third investigator (Mr Davor Jurkovic) who was 
blinded to the results of all previous ultrasound assessments of the uteri. This was in order to 
assess inter-observer agreement in the ultrasound diagnosis of adenomyosis based on 
assessment of stored 3D ultrasound volumes of uteri. 
 
3.3 STATISTICAL ANALYSIS  
Statistical analysis was performed, using SPSS software (SPSS Inc., Chicago IL). Intra- and 
inter-observer agreement was assessed for the diagnosis of adenomyosis, assessment of the 
91 
 
number of ultrasound features of adenomyosis observed and subjectively assessed severity of 
adenomyosis and for the classification of each ultrasound feature of adenomyosis. Weighted 
and unweighted kappa analysis was used to assess the level of agreement in all cases. 
  
3.4 RESULTS 
 
The median age of the 36 women included in the data analysis was 41 (inter-quartile range: 
35-47.75). 10/36 [27.7% (95% CI: 13.2% to 42.4%)] women were nulligravid and 12/36 
[33.3% (95% CI: 17.9% to 48.7%)] were nulliparous. 6/36 [16.7% (95%CI; 4.5% to 28.8%)] 
women were menopausal. The indications for ultrasound scans are listed in Table 14.  A total 
of 22/36 [60.1% (95% CI: 44.1% to 76.1%)] women had at least one ultrasound feature of 
adenomyosis at their original real-time ultrasound scan. The total number of ultrasound 
features seen on different scans can be seen in Table 15. 12/36 (33.3%) women had uterine 
fibroids and 2/36 (5.6%) women had endometrial polyps. 
 
There was good intra-observer agreement, both when the observer was comparing real-time 
scan diagnosis of adenomyosis to diagnosis from stored uterine volumes, and when the 
observer was comparing two assessments of stored uterine volumes performed on two 
separate occasions, with kappa values of 0.67 and 0.83 respectively (Tables 16 and 21). There 
remained a good level of intra-observer agreement when comparison was made of the 
number of ultrasound features of adenomyosis recorded, with linear-weighted kappa values 
of 0.64 and 0.77 (Tables 17 and 22). There was excellent intra-observer agreement (kappa = 
0.83) in the subjective assessment of severity of adenomyosis between the two evaluations of 
the stored uterine volumes (Table 23). 
When two different operators assessed stored uterine volumes, there was good inter-observer 
agreement for the diagnosis of adenomyosis (kappa = 0.61) (Table 18), the number of 
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ultrasound features of adenomyosis seen (linear-weighted kappa = 0.63) (Table 19) and 
subjective assessment of severity of adenomyosis (linear-weighted kappa = 0.61) (Table 20). 
 
Table 14 - Indications for ultrasound scan 
Indication for ultrasound scan n (%) 
Pelvic pain 
Menstrual symptoms 
PCB/IMB/PMB 
Ovarian surveillance 
Subfertility 
Other 
9 
9 
6 
6 
4 
3 
 
 
 
Table 15 - Number of ultrasound features of adenomyosis seen on original real-time scan 
Number of features seen n (%) 
0 
1 
2 
3 
4 
5 
6 
7 
14 (38.9) 
4 (11.1) 
3 (8.3) 
5 (13.9) 
4 (11.1) 
4 (11.1) 
2 (5.6) 
0 (0) 
Total 36 (100) 
 
 
 
Table 16 - Kappa analysis of intra-observer agreement between diagnosis of adenomyosis on 
real-time ultrasound scan (operator 1) and on stored uterine volumes (operator 1) 
 Diagnosis on stored volume (operator 1) 
Real time 
ultrasound 
diagnosis 
(operator 1) 
 Not 
adenomyosis 
Adenomyosis Total 
Not 
adenomyosis 
13 1 14 
Adenomyosis 5 17 22 
Total 18 18 36 
k=0.667 (good agreement) 
95%CI (0.429-0.904) 
Standard error of kappa = 0.121 
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Table 17 - Linear-weighted kappa analysis of agreement on the number of ultrasound features 
seen on real-time ultrasound scan (operator 1) and on stored uterine volumes (operator 1) 
 Number of ultrasound features of adenomyosis seen on stored 
uterine volumes (operator 1) 
 
Number of 
ultrasound 
features of 
adenomyosis 
seen on real-
time 
ultrasound 
scan 
(operator 1) 
 0 1 2 3 4 5 6 7 Total 
0 13 0 1 0 0 0 0 0 14 
1 2 1 1 0 0 0 0 0 4 
2 2 0 1 0 0 0 0 0 3 
3 0 1 1 2 0 1 0 0 5 
4 1 0 2 0 1 0 0 0 4 
5 0 0 0 2 0 2 0 0 4 
6 0 0 0 0 1 0 1 0 2 
7 0 0 0 0 0 0 0 0 0 
Total 18 2 6 4 2 3 1 0 36 
Linear-weighted kappa = 0.64 (good agreement) 
95% CI (0.47-0.80) 
Standard error of kappa = 0.082 
 
 
Table 18 - Kappa analysis of agreement of diagnosis of adenomyosis on stored uterine 
volumes (operator 1 and 2) 
 Diagnosis on stored volume (operator 1) 
Real time 
ultrasound 
diagnosis 
(operator 1) 
 Not adenomyosis Adenomyosis Total 
Not adenomyosis 13 5 18 
Adenomyosis 2 16 18 
Total 15 21 36 
k=0.61 (good agreement) 
95%CI (0.36-0.87) 
Standard error of kappa = 0.130 
 
 
Table 19a - Linear-weighted kappa analysis of inter-observer agreement on the number of 
ultrasound features seen on stored uterine volumes (operator 1 and 2) 
 Number of ultrasound features of adenomyosis seen on stored 
uterine volumes (operator 2) 
 
Number of 
ultrasound 
features of 
adenomyosis 
seen on real-
time 
ultrasound 
scan 
(operator 1) 
 0 1 2 3 4 5 6 7 Total 
0 13 1 3 1 0 0 0 0 18 
1 0 1 1 0 0 0 0 0 2 
2 2 0 2 2 0 0 0 0 6 
3 0 0 1 3 0 0 0 0 4 
4 0 0 0 1 1 0 0 0 2 
5 0 0 0 1 1 0 1 0 3 
6 0 0 0 0 1 0 0 0 1 
7 0 0 0 0 0 0 0 0 0 
Total 15 2 7 8 3 0 1 0 36 
Linear-weighted kappa = 0.63 (good agreement) 
95% CI (0.47 - 0.78) 
Standard error of kappa = 0.078 
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Table 19b – Table showing the kappa values for inter-observer agreement between the 
presence of individual ultrasound features of adenomyosis (operator 1 and 2) 
Ultrasound feature Kappa value (95% CI) 
Asymmetrical thickening 0.771 (0.53-1) 
Parallel shadowing 1 (1-1) 
Linear striations 0.571 (0.29-0.85) 
Myometrial cysts 0.487 (0.22-0.753) 
Hyperechoic islands 0.478 (0.135-0.822) 
Adenomyomas 0 (0-0) 
Irregular EMJ 0.650 (0.398-0.903) 
 
 
Table 20 - Linear-weighted kappa analysis of inter-observer agreement on the severity of 
adenomyosis on stored uterine volumes (operator 1 and 2) 
 Subjective assessment of severity of adenomyosis on 
stored uterine volumes (operator 2) 
 
Subjective 
assessment of 
severity of 
adenomyosis 
on uterine 
volumes 
(operator 1) 
 Absent Mild Moderate Severe Total 
Absent 13 5 0 0 18 
Mild 2 5 2 0 9 
Moderate 0 1 2 0 3 
Severe 0 1 3 2 6 
Total 15 12 7 2 36 
Linear-weighted kappa = 0.61 (good agreement) 
95%CI (0.44-0.78) 
Standard error of kappa = 0.087 
 
 
 
Table 21 - Kappa analysis of intra-observer agreement of diagnosis of adenomyosis on stored 
uterine volumes (operator 1) 
 Diagnosis on stored volume (operator 1) 
Real time 
ultrasound 
diagnosis 
(operator 1) 
 Not adenomyosis Adenomyosis Total 
Not adenomyosis 16 2 18 
Adenomyosis 1 17 18 
Total 17 19 36 
k=0.83 (excellent agreement) 
95%CI (0.65-1.0) 
Standard error of kappa = 0.092 
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Table 22 - Linear-weighted kappa analysis of intra-observer agreement on the number of 
ultrasound features seen on stored uterine volumes (operator 1) 
 Number of ultrasound features of adenomyosis seen on stored 
uterine volumes (operator 2) 
 
Number of 
ultrasound 
features of 
adenomyosis 
seen on real-
time 
ultrasound 
scan 
(operator 1) 
 0 1 2 3 4 5 6 7 Total 
0 16 1 1 0 0 0 0 0 18 
1 0 0 1 1 0 0 0 0 2 
2 1 1 3 0 1 0 0 0 6 
3 0 1 1 2 0 0 0 0 4 
4 0 0 0 0 1 1 0 0 2 
5 0 0 0 0 1 1 1 0 3 
6 0 0 0 0 0 0 1 0 1 
7 0 0 0 0 0 0 0 0 0 
Total 17 3 6 3 3 2 2 0 36 
Linear-weighted kappa = 0.77 (good agreement) 
95% CI (0.65 - 0.90) 
Standard error of kappa = 0.064 
 
 
Table 23 - Linear-weighted kappa analysis of intra-observer agreement on the severity of 
adenomyosis on stored uterine volumes (operator 1) 
 Subjective assessment of severity of adenomyosis on 
stored uterine volumes (operator 2) 
 
Subjective 
assessment of 
severity of 
adenomyosis 
on uterine 
volumes 
(operator 1) 
 Absent Mild Moderate Severe Total 
Absent 16 1 1 0 18 
Mild 1 6 2 0 9 
Moderate 0 0 3 0 3 
Severe 0 0 1 5 6 
Total 17 7 7 5 36 
Linear-weighted kappa = 0.83 (excellent agreement) 
95%CI (0.70-0.97) 
Standard error of kappa = 0.067 
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[3] HOW COMMON IS ADENOMYOSIS? A PROSPECTIVE STUDY OF 
PREVALENCE USING TRANSVAGINAL ULTRASOUND IN A GYNAECOLOGY 
CLINIC 
  
3.1 BACKGROUND  
The reliance on histological assessment of hysterectomy specimens for the diagnosis of 
adenomyosis has presented many difficulties in accurately assessing its prevalence. The lack 
of clear and uniform histological criteria raises concerns about the reproducibility of 
histological diagnosis of adenomyosis and partially explains the variation in the proportions 
of women diagnosed with adenomyosis in different studies (Bergholt et al, 2001). 
Furthermore, the reliance on histology for diagnosis introduces a heavy selection bias as only 
women who have undergone a hysterectomy can be diagnosed with the disease. This bias has 
been further amplified by the reduction in the number of hysterectomies being performed for 
benign disease (Reid and Mukri, 2005), resulting in the population of women from which 
conclusions are drawn becoming increasingly less representative of the general population.  
Continuous improvements in the resolution of TVUS have now enabled a more detailed 
assessment of uterine architecture. This has facilitated the detection of subtle features of 
adenomyosis, which could not have been seen with older equipment. TVUS, along with MRI, 
has recently been shown to have good levels of accuracy in the pre-operative diagnosis of 
adenomyosis (Dueholm 2006). TVUS is relatively inexpensive, widely available and well-
tolerated by patients. The aim of this study was to assess the prevalence of adenomyosis in a 
population of women attending general gynaecological clinic using transvaginal ultrasound. 
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3.2 METHODS 
This was a prospective observational study of women attending our general gynaecology 
clinic between January 2009 and January 2010.  In all women, demographic data were 
recorded and a detailed clinical history was taken prior to undertaking the ultrasound scan. 
This included women’s age, ethnicity, body mass index (kg/m2), smoking history, age at 
menarche, gravidity and parity (number of all prior pregnancies: miscarriages, terminations 
of pregnancy and live births including mode of delivery), breastfeeding history (months of 
breastfeeding), contraceptive history (length of time taking exogenous hormones, IUCD 
usage) and menopausal status. Body mass index was calculated based on self-reported weight 
and height. Women who were not certain of these measurements had their height and weight 
measured using a calibrated scale and stadiometer. 
Women were considered to have a history of endometriosis, if it had been diagnosed 
previously on laparoscopy or on ultrasound scan within our department using the criteria 
previously described in the methods section. In women who subsequently underwent 
hysterectomy, ultrasound findings were compared with the final histological diagnosis. 
Histopathological examinations were performed according to Molitor’s method (Molitor, 
1971).  
  
3.3 STATISTICAL ANALYSIS 
Statistical analysis was performed, to examine possible associations between various 
demographic and clinical variables and the presence of adenomyosis, using logistic 
regression. Initially the individual effect of each factor upon the outcome was assessed in a 
series of univariable analyses. Subsequently the joint effect of the variables was examined in 
a multivariable analysis. Before the multivariable analysis, variance inflation factors (VIFs) 
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were used to examine the colinearity between the variables. Statistical analysis was 
performed using SPSS software (SPSS Inc., Chicago IL). Kappa analysis was used to 
determine the level of agreement between ultrasound and histological diagnosis of 
adenomyosis. 
  
3.4 RESULTS 
A total of 1066 consecutive women attended for clinical visits. None of them were pre-
menarchal or pregnant. 45/1066 [4.2% (95%CI: 3.8%-5.6%)] women were excluded from the 
data analysis as they were unable to undergo a transvaginal scan. A further 36/1066 [3.4% 
(95%CI: 2.5%-4.6%)] women were excluded as they had previously undergone a 
hysterectomy. The median age of the 985 women included in the final data analysis was 40 
(inter-quartile range: 32-48). 387/985 [39.3% (95% CI: 36.3%-42.4%)] women were 
nulligravid and 529/985 [53.7% (95% CI: 50.6%-56.8%)] were nulliparous. 174/985 [17.7% 
(95%CI: 15.4%-20.2%)] women were menopausal. The indications for clinical visits are 
listed in Table 24. The diagnoses following ultrasound assessment are listed in Table 25.  A 
total of 206/985 [20.9% (95% CI: 18.5% - 23.6%)] women were diagnosed with 
adenomyosis. In 78/206 (37.9%) of them, adenomyosis was an isolated abnormality, whilst in 
128/206 (62.1%) of women concomitant abnormalities were found (Table 26). 
 
The results of the univariable analysis examining associations of demographic and clinical 
factors with adenomyosis are shown in Table 27. The multivariable analysis (Table 28) 
showed that age, gravidity and pelvic endometriosis were all significantly associated with the 
presence of adenomyosis. The prevalence of adenomyosis increased with age, reaching a 
peak between the ages of 40 and 59, after which the prevalence decreased. Women with a 
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previous or current diagnosis of endometriosis were significantly more likely to have 
adenomyosis with an odds ratio of 4.06 (95% CI: 2.25-7.33). 
Of the 985 women, 45 [4.6% (95% CI: 3.4%-6.1%)] underwent hysterectomy within two 
years of their ultrasound scans. Of the 45 women who underwent hysterectomy, 19 did so for 
suspected gynaecological malignancies, 9 for menorrhagia, 6 for pelvic organ prolapse, 5 for 
urinary symptoms, 2 for pain symptoms and a further 2 had a hysterectomy prophylactically 
as they had a genetic predisposition to hereditary non-polyposis colorectal cancer. Women 
with uterine cancer (12 women with endometrial cancer and 2 with uterine sarcomas) or very 
large fibroids (4 women) were not used for comparison between TVUS and histology as their 
pathologies became the primary focus of histological examination. The invasive nature of the 
uterine cancers interfered with assessment of the EMJ and the overall uterine size of those 
women with very large numbers of fibroids made it difficult to obtain systematic 
representative sections from every part of the pathological specimens. The sensitivity and 
specificity of ultrasound in diagnosing adenomyosis in the remaining women was 81.8% 
(95% CI: 52.3%-94.9%) and 81.3% (95% CI: 57.0%-93.4%). The positive predictive value 
was 75% (95% CI: 42.8%-93.3%) and the negative predictaive value was 86.7% (95% CI: 
58.4%-97.7%). A kappa analysis showed a good level of agreement between histology and 
transvaginal ultrasound in the diagnosis of adenomyosis [Kappa=0.62 (p=0.001), 95% CI 
(0.32-0.91)]. 
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Table 24 – Primary indications for scan (Naftalin et al. 2012b) 
Indication for TVUS n (%) 
Menorrhagia 121 (12.3) 
Dysmenorrhoea 
Menorrhagia / dysmenorrhoea 
Pelvic pain 
18 (1.8) 
30 (3.0) 
187 (18.9) 
Infertility 
Irregular bleeding / amenorrhoea 
Postmenopausal bleeding 
Other 
129 (13.1) 
154 (15.6) 
80 (8.1) 
266 (27.0) 
 
 
 
Table 25 - Summary of ultrasound diagnoses recorded in the study population (n=985) 
(Naftalin et al. 2012b) 
Ultrasound diagnosis n (%) 
No pathology 
Adenomyosis 
Fibroids 
Endometriosis 
Polycystic ovaries 
Adnexal tumours 
Thick endometrium in postmenopause 
Endometrial polyps 
Pelvic adhesions 
Major congenital uterine anomalies 
Other 
210 (48.7) 
206 (20.9) 
346 (35.1) 
63 (6.4) 
164 (16.6) 
101 (10.3) 
47 (4.8) 
45 (4.6) 
26 (2.6) 
8 (0.8) 
9 (0.9) 
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Table 26 - Concomitant abnormalities found in women with adenomyosis (n=206) (Naftalin 
et al. 2012b) 
Concomitant abnormalities n (%) 
Fibroids 
Endometriosis 
Polycystic ovaries 
Adnexal tumours 
Thick endometrium in postmenopause 
Endometrial  polyps 
Pelvic adhesions 
Major congenital uterine anomalies 
Two or more pathologies 
No additional pathology 
47 (22.8) 
10 (4.9) 
10 (4.9) 
17 (8.3) 
1 (0.5) 
2 (1.0) 
1 (0.5) 
0 (0) 
40 (19.4) 
78 (37.9) 
Total 206 (100) 
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Table 27 – Results of univariable analysis looking at associations between demographic and clinical factors and 
adenomyosis (Naftalin et al. 2012b) 
Variable Category/term Adenomyosis, n (%) Odds ratio (95% CI) p-value 
Age
a 
Linear term 
Square term 
 65.3 (19.4, 220) <0.001 
Ethnicity Caucasian 
Asian 
Afro-caribbean 
Oriental 
Middle eastern 
Mixed/other 
119/640 (19) 
25/80 (31) 
35/149 (23) 
8/38 (21) 
10/40 (25) 
7/38 (18) 
1 
1.99 (1.19, 3.32) 
1.34 (0.88, 2.06) 
1.17 (0.52, 2.61) 
1.46 (0.69, 3.07) 
0.99 (0.43, 2.30) 
 
 
 
 
 
0.14 
Smoking (pack years) 0 
1-10 
>10 
84/426 (20) 
56/290 (19) 
31/116 (27) 
1 
0.97 (0.67, 1.42) 
1.48 (0.92, 2.39) 
 
 
0.21 
BMI
b
 (kg/m
2
)
 
  1.20 (1.03, 1.41) 0.02 
Gravidity 0 
>1 
39/387 (10) 
165/598 (28) 
1 
3.40 (2.33, 4.95) 
 
<0.001 
Gravidity (detailed) 0 
1 
2 
3-5 
>6 
39/387 (10) 
38/187 (20) 
35/131 (27) 
65/220 (30) 
27/60 (45) 
1 
2.28 (1.40, 3.70) 
3.25 (1.96, 5.41) 
3.74 (2.41, 5.81) 
7.30 (3.98, 13.4) 
 
 
 
 
<0.001 
Parity 0 
1 
2 
>3 
75/529 (14) 
38/170 (22) 
50/151 (33) 
44/135 (33) 
1 
1.83 (1.18, 2.83) 
3.14 (2.06, 4.78) 
3.07 (1.98, 4.75) 
 
 
 
<0.001 
Vaginal deliveries 0 
1 
2 
>3 
91/607 (15) 
39/150 (26) 
45/127 (35) 
29/101 (29) 
1 
1.99 (1.30, 3.06) 
3.11 (2.03, 4.77) 
2.28 (1.41, 3.71) 
 
 
 
<0.001 
Caesarean deliveries 0 
>1 
166/869 (19) 
38/116 (33) 
1 
2.06 (1.35, 3.15) 
 
0.001 
Miscarriages 0 
>1 
141/772 (18) 
63/213 (29) 
1 
1.85 (1.30, 2.61) 
 
0.001 
ERPC or STOP 0 
>1 
119/705 (17) 
85/280 (30) 
1 
2.15 (1.56, 2.96) 
 
<0.001 
Breastfeeding
 
<6 months 
> 6 months 
32/112 (29) 
34/102 (33) 
1 
1.19 (0.76, 1.87) 
 
0.44 
Age at menarche   1.02 (0.93, 1.12) 0.71 
Use of intrauterine 
contraceptive devices 
No 
Yes 
100/519 (19) 
44/151 (29) 
1 
1.72 (1.14, 2.60) 
 
0.01 
Time on combined oral 
contraceptive pill (years) 
0 
<1 
1-5 
5-10 
>10 
77/328 (24) 
22/162 (14) 
46/215 (21) 
38/174 (22) 
21/106 (20) 
1 
0.51 (0.30, 0.86) 
0.88 (0.58, 1.34) 
0.91 (0.58, 1.41) 
0.80 (0.47, 1.38) 
 
 
 
 
0.15 
Time on progesterone-
only contraception (years) 
0 
<1 
1-5 
>5 
149/793 (19) 
24/75 (32) 
21/87 (24) 
10/30 (33) 
1 
2.03 (1.21, 3.40) 
1.37 (0.81, 2.31) 
2.15 (0.99, 4.70) 
 
 
 
0.01 
Menopausal status No 
Yes 
169/811 (21) 
35/174 (20) 
1 
0.96 (0.64, 1.44) 
 
0.83 
Endometriosis No 
Yes 
179/922 (19) 
25/63 (40) 
1 
2.73 (1.61, 4.64) 
 
<0.001 
Fibroids No 
Yes 
127/639 (20) 
74/346 (21) 
1 
1.08 (0.78, 1.49) 
 
0.63 
a
 – Odds ratio given for 10-unit increase in explanatory variable 
 
b
 – Odds ratio given for 5-unit increase in explanatory variable 
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Table 28 - Results of multivariate analysis looking at associations between demographic and 
clinical variables and adenomyosis (Naftalin et al. 2012b) 
Variable Category / term Odds Ratio (95% CI) P-value 
Age
 (**)
 Linear term 34.3 (9.9, 118) <0.001 
 Squared term 0.70 (0.62, 0.80)  
    
Gravidity  0 1  
 1 1.83 (1.09, 3.06)  
 2 2.46 (1.44, 4.30)  
 3-5 2.66 (1.62, 4.28)  
 6+ 4.90 (2.57, 9.35) <0.001 
    
Endometriosis No 1  
 Yes 4.06 (2.25, 7.33) <0.001 
    
 
(**)  Odds ratios given for a 10-unit increase in explanatory variable  
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[4] IS ADENOMYOSIS ASSOCIATED WITH MENORRHAGIA?  
 
4.1 BACKGROUND  
 
Original descriptions of adenomyosis reported an association with heavy and prolonged 
periods (Cullen 1908). Several later studies reported similar findings (Emge et al. 1962; Bird 
et al. 1972; Benson and Sneedon, 1958), but others have not shown significant differences in 
the prevalence of adenomyosis between women with and without a history of menorrhagia 
(Bergholt et al. 2001; Levgur et al. 2000; Parrazzini et al. 1997; Weiss et al. 2009). Most of 
these studies used retrospective histological examination of hysterectomy specimens to 
diagnose adenomyosis and compare it to clinical symptoms. The main problem with the use 
of histology for the diagnosis of adenomyosis in these studies is the heavy selection bias 
incurred (Mehasseb and Habiba 2009). Furthermore, in retrospective studies it is very 
difficult to account for confounding variables such as concomitant uterine fibroids which 
have an independent adverse effect on menstrual periods. 
TVUS has recently been used for the non-invasive diagnosis of adenomyosis (Kepkep et al. 
2007) and to study its prevalence (Naftalin et al. 2012b). There have been no large scale 
prospective studies using non-invasive techniques to assess the link between adenomyosis 
and clinical symptoms. The aim of this study was to investigate the possible association 
between adenomyosis and menorrhagia.  
 
4.2 METHODS  
This was a prospective observational study of premenopausal women attending our general 
gynaecology clinic. In all women, a detailed clinical history was taken prior to undertaking 
the ultrasound scan. Women were asked about the frequency and duration of menstrual 
periods and about any episodes of intermenstrual or postcoital bleeding. The amount of 
menstrual loss was assessed subjectively by asking whether they felt their periods were 
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excessively heavy or not. We also asked a subgroup of women to complete a PBAC in order 
to obtain  semi-quantitative information about the amount of menstrual loss. Women were 
advised to complete the chart during their next period and then to return it back to the 
department by post (a stamped addressed envelope was provided).   
Women who were unable to undergo a TVUS or had previously undergone a hysterectomy 
and those with a history of amenorrhoea or oligomenorrhoea with a cycle length greater than 
60 days were excluded from the study. Women using contraceptives or taking medications 
that would affect menstrual flow, women who attended for ultrasound scan during their IVF 
cycle and those who underwent hysterectomy prior to their next period following the scan 
were not asked to complete a PBAC. 
  
4.3 STATISTICAL ANALYSIS  
Statistical analysis was performed in two stages, first for subjective assessment of 
menorrhagia and then for the semi-quantitative assessment of menstrual loss. Regression 
methods were used to examine possible associations between various demographic and 
clinical variables and menorrhagia. The subjective measure was a binary outcome, and so the 
analysis of this outcome was performed using logistic regression. The PBAC scores were 
measured on a continuous scale and so linear regression was used for the analysis. The scores 
were found to have a heavily positively skewed distribution and so were given a log 
transformation before analysis.  
The analyses themselves were performed in two stages. Initially the separate association of 
each factor with the outcome was examined in a series of univariable analyses. Subsequently 
the joint effect of the variables upon each outcome was assessed in a multivariable analysis. 
To limit the number of variables in this analysis, only factors with a univariable p-value of 
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<0.2 were considered for this stage of the analysis. A backwards selection procedure was 
used to retain only the statistically significant variables in the final model. As menstrual loss 
was analysed on a log scale, the results are summarised in the form of ratios whereby the 
ratios represent the PBAC values when the symptoms was present relative to when it was 
absent. A Kappa analysis was used to analyse the agreement between the subjective 
assessment of menorrhagia and the PBACs, where a PBAC score >100 was considered to be 
consistent with menorrhagia. 
  
4.4 RESULTS  
A total of 892 consecutive premenopausal women attended for clinic visits between January 
2009 and January 2010. 178 women were excluded (Figure 23) and 714 were entered into the 
data analysis. Their median age was 38 (IQR 30-43). 305 women [42.7% (95% CI. 39.1%-
46.4%)] women were nulligravid and 424 [59.4% (95% CI. 55.7% - 63.0%)] were 
nulliparous. Principal indications for ultrasound scans are listed in Table 29. The diagnoses 
following ultrasound assessment are listed in Tables 30 & 31. All 714 women were entered 
into data analysis for subjective assessment of menorrhagia. 529 women were asked to 
complete PBACs and the analysis of the semi-quantitative assessment of menstrual loss was 
performed in the 304 women who returned their charts. There was moderately good 
agreement between the subjective binary assessment of menorrhagia and thePBAC 
assessment of menstrual loss, where a PBAC score of >100 was considered to be consistent 
with menorrhagia (k=0.529; 95% CI, 0.435 to 0.623) (Table 32). 
The results of the univariable analysis examining the associations of demographic and 
clinical variables with subjective assessment of menorrhagia are shown in Table 33. The 
multivariable analysis (Table 34) showed that BMI, gravidity, fibroids, in particular sub-
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mucous fibroids and endometrial polyps were all significantly associated with menorrhagia. 
Adenomyosis, when assessed as a binary outcome, was not significantly associated with 
subjective assessment of menorrhagia. There was, however a significant positive correlation 
between the number of features of adenomyosis on ultrasound scan and the volume of 
menstrual loss expressed as a PBAC score, with each additional feature of adenomyosis being 
associated with an average 22% [95% CI. 6% - 42% (p=0.005)] increase in the PBAC value 
(Figure 24). 
Two further multivariable analyses were performed to compare the number of different 
morphological features of adenomyosis recorded on ultrasound in individual women and the 
presence of subjectively assessed menorrhagia. The first showed a significant positive 
relationship between the number of ultrasound features of adenomyosis and menstrual loss 
(Table 35 – Model 1). The second multivariable analysis (Table 35 - Model 2) compared 
women with no adenomyosis, women with <4 and those with >4 ultrasound features of 
adenomyosis. This analysis showed women with >4 ultrasound features of adenomyosis, but 
not women with <4 ultrasound features of adenomyosis, were significantly more likely to 
suffer with menorrhagia. A breakdown of the number of ultrasound features of adenomyosis 
recorded in the study population can be seen in Table 36. A final analysis looked at the 
association between menorrhagia and the specific ultrasound features seen. The outcome 
variable in the analysis was PBAC score which was measured on a log scale therefore the 
outcomes are expressed as ratios (Table 37). The results for the individual features suggested 
that only asymmetrical thickening and irregular EMJ were strongly associated with the PBAC 
scores. The presence of these features was associated with a higher PBAC score. 
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Figure 23 – Flowchart showing why women were excluded from data analysis (Naftalin et al. 2014) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 29 – Principal indications for scan (n=714) (Naftalin et al. 2014) 
Principal indication for scan n (%) 
Menorrhagia 
Menorrhagia / dysmenorrhoea 
Intermenstrual / postcoital bleeding 
Mild Oligomenorrhoea 
Pelvic pain 
Dysmenorrhoea 
Dyspareunia 
Subfertility 
Recurrent miscarriage 
Other 
119 (16.7) 
31 (4.3) 
68 (9.5) 
66 (9.2) 
129 (18.1) 
18 (2.5) 
12 (1.7) 
115 (16.1) 
9 (1.3) 
147 (20.1) 
 
 
Table 30 - Summary of ultrasound diagnoses recorded in the study population (n=714) 
(Naftalin et al. 2014) 
Diagnosis n (%) 
No uterine pathology 
Adenomyosis 
Fibroids 
Endometrial polyp 
Two pathologies 
Three pathologies 
336 (47.1) 
100 (15.4) 
176 (24.6) 
32 (4.5) 
69 (9.7) 
1 (0.14) 
Total 714 (100) 
 
 
892 women 
assessed 
714 assessed for subjective menorrhagia 
529 women asked to fill in PBACs 
304 women returned completed PBACs 
Excluded from the study (178) 
46 – could not tolerate TVUS 
35 – prior hysterectomy 
94 - Cycles absent or >60 days 
3 - other 
 
Excluded from PBAC (185) 
122 – Using contraceptives that effect menstrual 
flow 
50 – Taking medications that effect menstrual flow 
9 – Had hysterectomies prior to next period 
4 – Had scans during IVF treatment cycles 
225 women did not return PBACs 
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Table 31 - Concomitant uterine abnormalities found in women with adenomyosis (n=157) 
(Naftalin et al. 2014) 
 n (%) 
Intramural/subserous fibroids 
Submucous fibroids 
Endometrial  polyp 
Two or more pathologies 
No additional pathology 
43 (27.4) 
10 (6.4) 
3 (1.9) 
1 (0.6) 
100 (63.7) 
Total 157 (100) 
 
 
Table 32 – Kappa analysis assessing agreement between subjective assessment of 
menorrhagia and PBAC charts (where PBAC score >100 considered to be consistent with 
menorrhagia) (Naftalin et al. 2014) 
 Subjective 
menorrhagia 
Subjectively 
normal 
 
PBAC score 
>100 
119 48 167 
PBAC score 
<100 
24 113 137 
 143 161 304 
k=0.529 (moderate agreement) 
95% CI (0.429-0.620) 
Standard error of kappa =0.048 
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Table 33 – Results of univariable analysis looking at associations between demographic and 
clinical factors and the subjective assessment of menorrhagia (n=714) (Naftalin et al. 2014) 
Variable Category Menorrhagia 
n (%) 
Odds Ratio  
(95% CI) 
P-value 
     
Age 
(*)
 -  1.31 (0.19, 1.44) <0.001 
     
BMI 
(*)
 -  1.50 (1.22, 1.84) <0.001 
     
Ethnicity Caucasian 198/442 (45%)    1 <0.001 
 Asian 37/66 (56%) 1.57 (0.94, 2.65)  
 Afro-Caribbean 79/122 (65%) 2.26 (1.49, 3.43)  
 Oriental 7/26 (27%) 0.45 (0.19, 1.10)  
 Middle Eastern 15/26 (58%) 1.68 (0.75, 3.74)  
 Mixed 16/32 (50%) 1.23 (0.60, 2.53)  
     
Gravidity 0 142/305 (47%)    1 <0.001 
 1 44/133 (33%) 0.57 (0.37, 0.87)  
 2-3 86/161 (53%) 1.32 (0.90, 1.93)  
 4+ 80/115 (70%) 2.62 (1.66, 4.14)  
     
Parity 0 180/418 (43%)    1 <0.001 
 1 47/105 (45%) 1.07 (0.70, 1.65)  
 2 36/61 (59%) 1.90 (1.10, 3.28)  
 3+ 89/130 (68%) 2.87 (1.89, 4.36)  
     
Adenomyosis No 256/558 (46%)    1  0.001 
 Yes 93/157 (59%) 1.89 (1.31, 2.71)  
     
Any fibroids No 197/470 (42%)    1 <0.001 
 Yes 155/244 (64%) 2.41 (1.75, 3.32)  
     
Submucous 
fibroids 
No 
Yes 
280/624 (45%) 
72/90 (80%) 
   1 
4.91 (2.86, 8.43) 
<0.001 
     
Fibroids None 197/470 (42%)    1 <0.001 
(combined) Any fibroids 83/154 (54%) 1.62 (1.12, 2.33)  
 Submucous 
fibroids 
72/90 (80%) 5.54 (3.20, 9.59)  
     
Endometrial 
polyps 
No 320/664 (48%)    1 0.03 
 Yes 32/50 (64%) 1.91 (1.05, 3.47)  
     
* Odds ratios given for 5-unit increase in explanatory variable 
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Table 34 – Results of multivariable analysis looking at associations between demographic 
and clinical factors and the subjective assessment of menorrhagia (n=714) (Naftalin et al. 
2014) 
Variable Category Odds Ratio (95% 
CI) 
P-value 
    
BMI 
(*)
 - 1.40 (1.13, 1.74) 0.002 
    
Gravidity 0 1 <0.001 
 1 0.34 (0.18, 0.64)  
 2-3 1.01 (0.59, 1.74)  
 4+ 2.33 (1.26, 4.30)  
    
Fibroids 
(combined) 
None 1 <0.001 
 Any fibroids 1.53 (0.91, 2.58)  
 Submucous fibroids 5.60 (2.69, 11.6)  
    
Endometrial polyps No 1 0.02 
 Yes 2.81 (1.15, 11.7)  
    
* Odds ratios given for 5-unit increase in explanatory variable 
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Table 35 – Results of multivariable analyses looking at the associations between 
demographic and clinical factors and the subjective assessment of menorrhagia, where the 
number of ultrasound features of adenomyosis was treated as a continuous variable (Model 1) 
and where the number of ultrasound features was treated as a categorical variable (Model 2) 
(n=714) (Naftalin et al. 2014) 
Variable Category Odds Ratio (95% 
CI) 
P-value 
    
Model 1    
    
BMI 
(*)
 - 1.38 (1.11, 1.71) 0.004 
    
Gravidity 0 1 <0.001 
 1 0.31 (0.16, 0.60)  
 2-3 0.84 (0.48, 1.48)  
 4+ 1.77 (0.92, 3.39)  
    
Adenomyosis features - 1.21 (1.04, 1.40) 0.01 
    
Fibroids (combined) None 1 <0.001 
 Any fibroids 1.53 (0.90, 2.58)  
 Submucous 
fibroids 
6.19 (2.96, 12.9)  
    
Endometrial polyps No 1 0.02 
 Yes 2.99 (1.21, 7.40)  
    
Model 2    
    
BMI 
(*)
 - 1.39 (1.11, 1.73) 0.003 
    
Gravidity 0 1 <0.001 
 1 0.31 (0.16, 0.59)  
 2-3 0.91 (0.51, 1.61)  
 4+ 2.01 (1.04, 3.92)  
    
Adenomyosis features None 1 0.002 
(categorical) 1 – 3 0.73 (0.39, 1.36)  
 4+ 3.80 (1.62, 8.91)  
    
Fibroids (combined) None 1 <0.001 
 Any fibroids 1.49 (0.88, 2.53)  
 Submucous 
fibroids 
6.16 (2.93, 12.9)  
    
Endometrial polyps No 1 0.02 
 Yes 2.87 (1.16, 7.11)  
    
* Odds ratios given for 5-unit increase in explanatory variable 
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Table 36 –The number of ultrasound features seen in the study population (n=157) (Naftalin 
et al. 2014) 
Number of ultrasound features of 
adenomyosis seen 
n (%) 
  
1 18 (11.5) 
2 37 (23.6) 
3 41 (26.1) 
4 32 (20.3) 
5 16 (2.2) 
6 10 (10.2) 
7 3 (1.9) 
  
 
 
 
 
Figure 24 – The relationship between increasing numbers of ultrasound features of 
adenomyosis and PBACassessed menstrual loss (n=304) (Naftalin et al. 2014) 
1
0
0
1
5
0
2
0
0
2
5
0
3
0
0
3
5
0
P
B
A
C
0 2 4 6 8
Number of adenomyosis features
 
 
 
 
 
 
 
 
 
 
114 
 
 
Table 37 – Results of the statistical analysis looking at the effect of the number and type of 
ultrasound features on the PBAC assessment of menorrhagia (n=304) (Naftalin et al. 2014) 
Outcome Ratio (95% CI) P-value 
   
Number of features 1.22 (1.06, 1.42)   0.005 
   
Asymmetrical thickening 2.24 (1.36, 3.68)   0.002 
Parallel shadowing 1.63 (0.80, 3.37) 0.18 
Linear striations 0.96 (0.56, 1.63) 0.88 
Myometrial Cysts 1.62 (0.99, 2.68) 0.06 
Hyperechoic lesions 0.82 (0.45, 1.51) 0.53 
Adenomyomas 1.07 (0.60, 1.89) 0.82 
Irregular EMJ 1.83 (1.10, 3.05) 0.02 
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[5] IS ADENOMYOSIS ASSOCIATED WITH DYSMENORRHOEA? 
 
5.1 BACKGROUND  
Original descriptions of adenomyosis reported an association between the disease and ‘a great 
deal of pain’ (Cullen, 1908). Several later studies reported similar findings (Emge 1962; Bird 
et al. 1972; Benson and Sneedon 1958), but others have not shown significant differences in 
the prevalence of adenomyosis between women with and without a history of dysmenorrhoea 
(Bergholt et al. 2001; Parrazzini et al. 1997; Weiss et al. 2009). Most of these studies used 
retrospective histological examination of hysterectomy specimens to diagnose adenomyosis 
and compare it to clinical symptoms. The main problem with the use of histology for the 
diagnosis of adenomyosis in these studies is the heavy selection bias incurred (Mehasseb and 
Habiba, 2009). Furthermore, in retrospective studies it is very difficult to account for 
confounding variables such as endometriosis which are considered to have an independent 
adverse effect on menstrual pain. 
TVUS has recently been used for the non-invasive diagnosis of adenomyosis (Kepkep et al. 
2007) and to study its prevalence (Naftalin et al. 2012b). There have been no large scale 
prospective studies using non-invasive techniques to assess the link between adenomyosis 
and clinical symptoms. The aim of this study was to investigate the possible association 
between adenomyosis and dysmenorrhoea. 
 
5.2 METHODS  
This was a prospective observational study of premenopausal women attending our general 
gynaecology clinic. In all women, a detailed clinical and demographic history was taken prior 
to undertaking the ultrasound scan. In addition, an assessment was made as to how painful 
their periods were using an 11-point NRS. Women who were unable to undergo a 
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transvaginal scan or had previously undergone a hysterectomy and those with a history of 
amenorrhoea or oligomenorrhoea with a cycle length greater than 60 days were excluded 
from the study. 
  
5.3 STATISTICAL ANALYSIS 
Regression methods were used to examine factors associated with the subjective assessment 
of dysmenorrhoea. As the NRS scores were measured on a continuous scale, linear regression 
was used for the analysis. The scores were found to be approximately normally distributed 
and thus no transformation of the scores was given. The analysis was performed in two 
stages. Initially the separate association of each factor with the outcome was examined in a 
series of univariable analyses. Subsequently the joint effect of the variables upon each 
outcome was assessed in a multivariable analysis. To limit the number of variables in this 
analysis, only factors with a univariable p-value of <0.2 were considered for this stage of the 
analysis. A backwards selection procedure was used to retain only the statistically significant 
variables in the final model. Two variables, gravidity and parity, were found to have a small 
number of very high values. As a result these two variables were categorised for the purposes 
of analysis. Statistical analysis was performed, using SPSS software (SPSS Inc., Chicago IL). 
 
5.4 RESULTS 
A total of 892 consecutive premenopausal women attended for clinic visits between January 
2009 and January 2010. 178 women were excluded (Figure 25) and 714 were entered into the 
data analysis. Their median age was 38 (IQR 30-43). 305/714 [42.7% (95% CI. 39.1%-
46.4%)] women were nulligravid and 424/714 [59.4% (95% CI. 55.7% - 63.0%)] were 
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nulliparous. Primary indications for ultrasound scans are listed in Table 38. The diagnoses 
following ultrasound assessment are listed in Tables 39 & 40.  
The results of the univariable analysis examining the associations of demographic and 
clinical variables with subjective assessment of dysmenorrhoea showed that there was a 
strong positive association between NRS score and the presence of both endometriosis and 
adenomyosis (Table 41). Women with adenomyosis had higher NRS scores, on average 1.1 
units higher than those without adenomyosis. Women with endometriosis had NRS scores 
that were on average 1.6 units higher than. No other variables were significantly associated 
with NRS scores. 
The multivariable analysis (Table 42) showed that, as in the univariable analyses, both 
adenomyosis and endometriosis had a significant association with dysmenorrhoea, as 
measured by NRS. The presence of either of these conditions was associated with higher pain 
scores. After adjusting for the effects of the other variable, the size of effects of each variable 
were slightly reduced from the size of effect observed in the univariable analyses. A linear 
regression analysis was performed assessing the association between both the number of 
ultrasound features of adenomyosis present and the specific ultrasound features seen. The 
outcome variable in the analysis was NRS score which was measured on a continuous scale. 
The NRS score was found to be approximately normally distributed. Linear regression was 
used to, in turn, to examine the effect of the total number of adenomyosis features, and the 
individual features, upon the outcome. The analysis of the NRS score included adjustments 
for both treatment and endometriosis, as these were thought to be potentially confounding 
factors. The shape of the relationship between the total number of features present and the 
outcome was examined. If the relationship was not found to be linear (a straight line), a 
curved relationship was assumed, which was achieved by adding a squared term into the 
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analysis. The results suggest that the number of ultrasound features of adenomyosis present 
was significantly associated with the NRS scores (Table 43). The relationship can be seen in 
Figure 26 which shows the fitted relationship between the number of ultrasound features of 
adenomyosis present and NRS score. The graph suggests that the number of features was not 
strongly associated with NRS score below around 4 features, however once the number of 
features was above this level, there was an increase in the pain score with increased number 
of features. The results for the individual features suggested that only asymmetrical 
thickening and irregular EMJ were strongly associated with the NRS scores. The presence of 
these features was associated with a higher NRS score. The largest effect was for irregular 
EMJ, where the presence of this symptom was associated with an increase of 1.6 units in the 
NRS score. A breakdown of the number of ultrasound features of adenomyosis seen in the 
study population can be seen in Table 44. 
 
 
Figure 25 – Flowchart showing why women were excluded from data analysis. 
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Table 38 – Primary indications for scan (n=714) 
Principal indication for scan n (%) 
Menorrhagia 
Menorrhagia / dysmenorrhoea 
Intermenstrual / postcoital bleeding 
Mild Oligomenorrhoea 
Pelvic pain 
Dysmenorrhoea 
Dyspareunia 
Subfertility 
Recurrent miscarriage 
Other 
119 (16.7) 
31 (4.3) 
68 (9.5) 
66 (9.2) 
129 (18.1) 
18 (2.5) 
12 (1.7) 
115 (16.1) 
9 (1.3) 
147 (20.1) 
 
 
 
Table 39 Summary of ultrasound diagnoses recorded in the study population (n=714) 
Ultrasound diagnoses n (%) 
No uterine pathology 
Adenomyosis 
Fibroids 
Endometrial polyp 
Two pathologies 
Three pathologies 
336 (47.1) 
100 (15.4) 
176 (24.6) 
32 (4.5) 
69 (9.7) 
1 (0.14) 
Total 714 (100) 
 
 
 
Table 40 - Concomitant uterine abnormalities found in women with adenomyosis (n=157) 
Concomitant uterine abnormalities n (%) 
Intramural/subserous fibroids 
Submucous fibroids 
Endometrial  polyp 
Two or more pathologies 
No additional pathology 
43 (27.4) 
10 (6.4) 
3 (1.9) 
1 (0.6) 
100 (63.7) 
Total 157 (100) 
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Table 41 - Results of univariable analysis looking at associations between demographic and 
clinical factors and the subjective assessment of dysmenorrhoea (n=714) 
Variable Category  Coefficient (95% CI) P-value 
    
Age 
(*)
 - -0.04 (-0.17, 0.09) 0.53 
    
BMI 
(*)
 - 0.24 (-0.04, 0.51) 0.09 
    
Ethnicity Caucasian 0 0.10 
 Asian 0.71 (-0.04, 1.46)  
 Afro-Caribbean 0.36 (-0.22, 0.93)  
 Oriental -0.91 (-2.06, 0.24)  
 Middle Eastern 0.28 (-0.87, 1.43)  
 Mixed 0.77 (-0.27, 1.82)  
    
Gravidity 0 0 0.99 
 1 -0.03 (-0.62, 0.57)  
 2-3 0.02 (-0.53, 0.58)  
 4+ 0.02 (-0.61, 0.64)  
    
Parity 0 0 0.89 
 1 -0.20 (-0.82, 0.42)  
 2 -0.11 (-0.89, 0.68)  
 3+ -0.17 (-0.75, 0.40)  
    
Adenomyosis No 0 <0.001 
 Yes 1.07 (0.56, 1.58)  
    
Any fibroids No 0 0.38 
 Yes 0.20 (-0.25, 0.65)  
    
SM fibroids No 0 0.25 
 Yes -0.37 (-1.02, 0.27)  
    
Fibroids (combined) None 0 0.11 
 Non SM fibroids 0.47 (-0.06, 1.00)  
 SM fibroids -0.26 (-0.92, 0.39)  
    
Endometriosis No 0 <0.001 
 Yes 1.57 (0.77, 2.37)  
    
(*) Regression coefficients given for a 5-unit increase in explanatory variable 
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Table 42 - Results of multivariable analysis looking at associations between demographic and 
clinical factors and the subjective assessment of dysmenorrhoea (n=714) 
Variable Category  Coefficient (95% CI) P-value 
    
Adenomyosis No     0 <0.001 
 Yes 0.94 (0.43, 1.46)  
    
Endometriosis No    0   0.001 
 Yes 1.36 (0.56, 2.17)  
    
 
 
 
Figure 26 – Relationship between the number of ultrasound features of adenomyosis present 
and NRS score. 
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Table 43 - Results of the statistical analysis looking at the effect of the number and type of 
ultrasound features on the subjective assessment of dysmenorrhoea (n=304) 
Outcome Term Coefficient (95% CI) P-value 
    
Number of features Linear -0.7 (-1.8, 0.4) <0.001 
 Squared 0.2 (0.0, 0.3)  
    
Asymmetrical thickening - 1.1 (0.2, 2.1) 0.02 
Parallel shadowing - 1.2 (-0.1, 2.5) 0.08 
Linear striations - 0.4 (-0.6, 1.3) 0.46 
Myometrial Cysts - 0.3 (-0.6, 1.3) 0.47 
Hyperechoic lesions - 0.3 (-0.8, 1.3) 0.62 
Adenomyomas - 0.1 (-1.0, 1.2) 0.86 
Irregular EMJ - 1.6 (0.7, 2.6)   0.001 
    
 
Table 44 – The number of ultrasound features seen in the study population (n=157) 
Number of ultrasound features of 
adenomyosis seen 
n (%) 
1 18 (11.5) 
2 37 (23.6) 
3 41 (26.1) 
4 31 (19.7) 
5 16 (2.2) 
6 10 (10.2) 
7 3 (1.9) 
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[6] EVALUATION OF A SECOND-STAGE TEST DESIGNED TO IMPROVE THE 
ACCURACY OF TRANSVAGINAL ULTRASOUND IN THE DIAGNOSIS OF 
ENDOMETRIAL CANCER 
 
6.1 BACKGROUND  
Endometrial cancer is the commonest cancer of the female genital tract in the developed 
world (Sankaranarayanan and Ferlay 2006). Ultrasound measurement of endometrial 
thickness is commonly used to triage women with post-menopausal bleeding for histological 
sampling. The cut-offs for endometrial sampling vary between different authors but >5mm is 
a commonly used cut-off. The sensitivity of this cut-off for diagnosing endometrial cancer is 
very high but the specificity is just 61% (CI: 59%-63%) (Smith-Bindman et al. 1998). 
Therefore the positive predictive value of endometrial thickness measurement in diagnosing 
endometrial cancer is poor and many women therefore undergo ultimately unnecessary 
invasive procedures.  
A number of attempts have been made to improve the specificity of ultrasound in diagnosing 
endometrial cancer. Many studies have assessed whether different endometrial morphologies 
are more common in malignant lesions (Epstein et al. 2001; Epstein et al. 2002, Epstein and 
Valentin 2006, Randelzhofer et al. 2002). Other authors have looked at various Doppler 
parameters to assess whether they aided diagnosis of endometrial cancer (Bourne et al. 1991; 
Epstein and Valentin 2006). 
The aim of our study was to assess whether a test that combined ultrasound examination of 
endometrial morphology and the integrity of the EMJ, with Doppler examination of the 
vasculature supplying endometrial lesions, could improve the specificity of ultrasound in 
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diagnosing endometrial cancer in women with postmenopausal bleeding and increased 
endometrial thickness on TVUS. 
6.2 METHODS 
This was a prospective observational study of women with a history of postmenopausal 
bleeding who attended our rapid-access clinic. In all women, a clinical history was taken and 
documented on a dedicated database (PIA Fetal Database, version 5.5.4.152, Viewpoint 
Bildverarbeitung GmbH, Munich, Germany). They all underwent clinical assessment which 
included speculum examination to exclude local vaginal and cervical abnormalities as a cause 
of bleeding prior to a TVUS. A smear test was performed only in women younger than 65 
who were not up-to-date with their smears. Women who had not been sexually active and 
those with severe atrophic vaginal changes were offered a transrectal scan. Women in whom 
transvaginal or transrectal scans were not possible and those in whom ultrasound images of 
the uterine cavity were sub-optimal were excluded from the study and advised to undergo 
hysteroscopy. Women were also excluded from the study if they were taking hormone 
replacement therapy (HRT) or if they had had endometrial sampling performed within the six 
months prior to attending the clinic. 
In women with suspected endometrial polyps or an endometrial thickness >5mm, a second-
stage test was performed at the same time as the initial ultrasound examination. The second 
stage test involved a detailed subjective assessment of endometrial morphology, the integrity 
of the EMJ alongside a Doppler assessment of the endometrium. The endometrium was 
classified as being either homogeneous or heterogeneous in the absence of focal pathology. If 
focal pathology was present it was classified as being either regular or irregular. The EMJ 
was assessed and classified as being either regular or irregular.  
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For the purposes of the study, the assessment of endometrial morphology was classified as 
suspicious if two criteria were met. The first criterion was that either focal pathology was 
present and irregular or, if no focal pathology was present, that the endometrium was 
heterogenous in echotexture (Figure 27). The second criterion was that there must be 
evidence that any lesion breached the EMJ (Figure 28). With regard to the Doppler 
assessment, lesions with no detectable blood supply and those with a single feeding vessel 
were classified as benign (Figure 29) whilst those supplied by multiple vessels crossing the 
EMJ were considered suspicious (Figure 30). 
Only women in whom both the endometrial morphology and the colour Doppler assessment 
were considered suspicious were classified, for the purposes of the study, as high risk for 
endometrial cancer. Patient management continued as per our clinical protocol and the 
ultrasound diagnosis was compared with the final histological diagnosis. 
  
6.3 STATISTICAL ANALYSIS  
A database file was set up using Microsoft Excel (Redmond, WA, US) for Windows to 
facilitate data entry and retrieval. Data were analysed using 2x2 tables to assess sensitivity 
and specificity. 
 
6.4 RESULTS 
125 women were assessed between September 2009 and November 2010. Eighteen women 
were excluded as they were using hormone replacement therapy. A further 7 women were 
excluded from statistical analysis; the endometrium could not be fully assessed on ultrasound 
in 4 of them, 2 of them declined surgery and 1 transferred her care to her local hospital 
following the ultrasound scan. Thus, 100 women were included in the study. Demographic 
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characteristics of the women included and excluded are shown in Table 45. The median age 
of women studied was 57.5 (inter-quartile range: 53-64). 20/100 [20% (95% CI: 12.2%-
27.8%)] women were nulliparous. There was a high burden of co-morbidity with 32% (95% 
CI: 22.9%-41.1%) having hypertension, 12% (95% CI: 5.6%-18.4%) being hypothyroid, 12% 
(95% CI: 5.6%-18.4%) taking anti-coagulants and 12% (95% CI: 5.6%-18.4%) being 
diabetic. 
Of the 100 women included, 49 had an endometrial thickness <5mm and no focal pathology. 
These women were reassured, discharged and advised to return should they experience any 
further vaginal bleeding. A histological diagnosis was obtained in all of the 51 women with 
either an endometrial thickness >5mm or focal pathology. The final diagnosis was obtained 
by pipelle in 15 cases and in a further 5 cases, pipelle sampling was inadequate and the 
women had to undergo an outpatient hysteroscopy to achieve a final diagnosis. 
10/11 (90.9%) women eventually diagnosed with endometrial cancer were correctly 
identified as high risk for endometrial cancer using the second-stage test (Table 46). The one 
false negative was a woman with a carcinosarcomatous endometrial polyp. While this had an 
unusual appearance on ultrasound, it did not fit the criteria for ultrasound diagnosis of 
endometrial cancer according to the study protocol, as the EMJ was intact and only a single 
blood vessel could be seen crossing the basal endometrium on colour Doppler assessment. 
There were three false positives. All three of these women had fibroids and two of them had 
adenomyosis. 
The sensitivity and specificity of the second-stage test in diagnosing endometrial cancer were 
90.9% (95% CI: 62.3% - 98.4%) and 96.6% (95% CI: 90.1% - 98.9%) respectively. 38 
women were classified as low risk for endometrial cancer of whom 37 had benign disease, 
giving a negative likelihood ratio of 0.094. Of the 13 women classified as high risk for 
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endometrial cancer, 10 were subsequently diagnosed with endometrial cancer, giving a 
positive likelihood ratio of 27.0. The effect of the second-stage test on the risk of endometrial 
cancer can be seen in Figure 31. 
When endometrial morphology alone was assessed, alongside endometrial thickness, the 
sensitivity and specificity in diagnosing endometrial cancer were 90.9% (95% CI: 62.3% - 
98.4%) and 95.5% (95% CI: 89% - 98.2%). The sensitivity was unchanged when Doppler 
assessment was analysed alone, alongside endometrial thickness and the specificity dropped 
slightly to 94.4% (95% CI: 87.5% - 97.6%). 
 
Figure 27 – Longitudinal view of a uterus with a heterogenous endometrium. The patient was 
subsequently diagnosed with endometrial cancer.  
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Figure 28 – Coronal view of a uterus where a hyperechoic tumour can be seen filling the right 
fundal portion of the endometrial cavity. A breach in the EMJ can be seen in the right 
cornuum (white arrow) 
 
 
 
Figure 29 – Longitudinal view of a uterus using B-mode ultrasound with colour Doppler 
showing an endometrial polyp with single feeder vessel. The polyp was found to be benign. 
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Figure 30 - Longitudinal view of a uterus using B-mode ultrasound with colour Doppler 
showing multiple vessels crossing the EMJ at the fundus. A pipelle biopsy subsequently 
revealed endometrial cancer. 
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Table 45 – Demographics of women included and excluded from the study 
Characteristic Included 
(n=100) 
Excluded 
(n=25) 
Total 
(n =125) 
Age in years (median; interquartile 
range) 
 
Endometrial thickness   mm (range) 
CI 
 
Nulliparous                     n (%) 
Hypertension                   n (%) 
Diabetes                          n (%) 
Use of anticoagulants     n (%) 
Use of levothyroxine      n (%) 
 
Final diagnosis 
 Malignant           n (%) 
  
Histological diagnosis obtained  
 Pipelle 
 Outpatient hysteroscopy 
 Inpatient hysteroscopy 
 Hysterectomy 
 
Final histological diagnosis 
 Atrophic/benign endometrium 
 Benign endometrial polyp 
 Simple hyperplasia 
 Complex hyperplasia 
 Cancer 
 
Histological subtype 
 Endometrioid adenocarcinoma 
 Carcinosarcoma 
 
Stage of Malignancies 
 I 
 II 
 III 
 IV 
 
57.5 (53-64) 
 
 
6.3 (0.8-56.3) 
(4.8-7.8) 
 
20 (20.0) 
32 (32.0) 
12 (12.0) 
12 (12.0) 
12 (12.0) 
 
 
11 (11.0) 
 
51 
15 
12 
23 
1 
 
 
16 
21 
3 
0 
11 
 
 
10 
1 
 
 
7 
1 
2 
1 
57 (53-63) 
 
 
7.5 (1.4-10.5) 
(1.9-13.1) 
 
7 (28.0) 
7 (28.0) 
2 (8.0) 
1 (4.0) 
1 (4.0) 
 
 
1 (4) 
 
19 
3 
2 
8 
2 
57 (53-64) 
 
 
7.4 (0.8-56.3) 
(5.9-8.9) 
 
27 (21.6) 
39 (31.2) 
14 (11.2) 
13 (10.4) 
13 (10.4) 
 
 
12 (9.6) 
 
70 
18 
14 
31 
3 
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Table 46 – Table showing how the endometria of women subsequently diagnosed with 
endometrial cancer were classified at the time of their original ultrasound scan. 
 
 
Figure 31 – Flowchart showing risks of endometrial cancer depending on results of TVUS 
Stage Endometrial 
thickness (mm) 
Endometrium EMJ Number of 
vessels 
Ultrasound 
classification 
Ia 
Ia 
Ia 
Ia 
Ia 
Ib 
Ib 
IIb 
IIIa 
IIIb 
IV 
8.3 
12.6 
12.9 
14.5 
17.7 
13 
26.1 
13.6 
5 
31.4 
56.3 
Irregular 
Irregular 
Irregular 
Irregular 
Irregular 
Regular 
Regular 
Irregular 
Irregular 
Regular 
Irregular 
Intact 
Disrupted 
Disrupted 
Intact 
Intact 
Disrupted 
Disrupted 
Disrupted 
Disrupted 
Intact 
Disrupted 
>2 
>2 
>2 
>2 
>2 
>2 
>2 
>2 
>2 
1 
>2 
Malignant 
Malignant 
Malignant 
Malignant 
Malignant 
Malignant 
Malignant 
Malignant 
Malignant 
Benign 
Malignant 
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IV Discussions 
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[1] INTER- AND INTRAOBSERVER VARIABILITY IN THREE-DIMENSIONAL 
ULTRASOUND ASSESSMENT OF THE ENDOMETRIAL-MYOMETRIAL 
JUNCTION 
  
1.0 DISCUSSION 
In this study, there was complete agreement between operators in classifying how well the 
EMJ could be visualised as optimal or sub-optimal, where sub-optimal included both 
satisfactory and unsatisfactory views. The discrepancies between operators occurred where 
EMJs were classified as either satisfactory or unsatisfactory. This is perhaps unsurprising as 
judging whether most of the EMJ can be seen or not is more subjective and hence more likely 
to suffer from inter-observer variability, than judging whether all of the EMJ can be seen. 
Despite the observed variability, the overall reproducibility of examination was very good 
with kappa values between 0.70 and 0.83. This indicates that assessment of the EMJ on 3D 
scan is reproducible enough to be used in clinical practice. This is important because 
assessment of the regularity or integrity of the EMJ is increasingly being used to make 
clinical diagnoses, mostly for the ultrasound diagnosis of adenomyosis (Ahmed et al. 2007; 
Exacoustos et al. 2011) but also for the diagnosis of endometrial cancer (Randelzhofer et al. 
2002). A reasonable reproducibility in the assessment of the EMJ should be considered a 
prerequisite if clinicians are to base clinical decisions on ultrasound findings. A criticism 
could be that the classification system used in this study was entirely arbitrary however there 
was no pre-existing classification system for assessment of the EMJ that could have been 
used. Furthermore, a similar approach has been used in the past when assessing 
reproducibility of ultrasound diagnosis of adnexal masses based on subjective evaluation 
(Yazbek 2010). It must be remembered that these results apply only to women with normal 
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uteri. Further work is needed to see if our findings are reproducible in different settings and 
different populations, more specifically, women with endometrial or myometrial pathology. 
In conclusion, this study shows that assessment of EMJ visualisation has both good inter- and 
intra-observer variability in women with normal uteri. 
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[2] FACTORS AFFECTING VISUALISATION OF THE EMJ ON THREE-
DIMENSIONAL ULTRASOUND 
 
2.0 DISCUSSION 
This study showed that the ability to analyse the EMJ improves with increasing endometrial 
thickness. This finding is consistent with MRI studies that show that EMJ thickness increases 
in parallel with, although not to the same extent as, endometrial thickness (Novellas 2011). 
Ultrasound studies have shown that endometrial echogenicity also increases in parallel with 
endometrial thickness, particularly in the luteal phase of the cycle (Fleischer 1986). This 
would increase the visual contrast between the endometrium and the myometrium, which 
could further facilitate visualisation of the EMJ. 
A more practical reason why increasing endometrial thickness enables better EMJ 
visualisation is that it allows greater flexibility in producing a clear rendered 3D coronal 
image. With a thin endometrium, curvature or asymmetry of the cavity can make it harder to 
find a plane through which the EMJ can be seen continuously. A thicker endometrium, and 
hence endometrial cavity, minimises this effect. 
Other work, including MRI studies, has shown that the EMJ changes in both appearance and 
size at different stages of the menstrual cycle
 
(McCarthy et al. 1986; Janus et al. 1988; 
Wiczyk et al. 1988). While our results were unable to show that stage of cycle had a 
significant effect on EMJ visualisation, this may be because the numbers were too small to 
determine a difference between the proliferative stage of the cycle and the luteal phase of the 
cycle, once post-menopausal women, women taking the pill and women with irregular cycles 
were excluded from the analysis. 
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We also found that the ability to see the EMJ decreases with increasing parity. The finding 
that parity has an effect on the EMJ is not unexpected. We know that the EMJ is involved in 
and changed by placentation (Brosens et al. 2010) and that there are differences in the 
appearance of the sub-endometria of nulliparous and multiparous women, as measured on 3D 
power Doppler angiography (Raine-Fenning et al. 2004). One might surmise that this effect 
was due to the presence of early or undiagnosed adenomyosis, a condition for which 
increased parity is thought to be a risk factor and which is known to affect the EMJ. This is 
purely speculative however, as none of the women included in the statistical analysis had any 
ultrasound features of adenomyosis, despite detailed assessment of the myometrium. 
The study by Raine-Fenning et al also showed a statistically significant negative correlation 
between age and sub-endometrial vascularity (Raine-Fenning et al. 2004). MRI studies have 
reported a change in EMJ size as age increases (Novellas 2011). We found that age did not 
have a statistically significant effect on EMJ visualisation. Comparisons between these 
studies are difficult however, as they either used different imaging modalities or assessed 
subtly different aspects of the EMJ. These two difficulties endure throughout the literature 
and are compounded by a paucity of published material assessing EMJ visualisation. 
Further work is needed to look at what factors, both physiological and pathological, affect the 
EMJ. 
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[3] INTER- AND INTRAOBSERVER VARIABILITY IN THE ULTRASOUND 
DIAGNOSIS OF ADENOMYOSIS 
 
3.0 DISCUSSION 
There was good intra-observer variability when comparing real-time B-mode ultrasound scan 
assessment and assessment of stored 3D uterine volumes for the diagnosis of adenomyosis, 
with a kappa value of 0.67. There was also good inter-observer variability when two different 
operators independently used assessment of stored 3D uterine volumes to diagnose 
adenomyosis, with a kappa value of 0.61. The intra- and inter-observer variability remained 
good or better when assessing agreement in the subjective classification of severity of 
adenomyosis on stored 3D uterine volumes, or in evaluating the number of ultrasound 
features of adenomyosis seen on stored 3D uterine volumes. When inter-observer variability 
was assessed there were seven disagreements in diagnosis. In all seven of these cases, the 
adenomyosis was subjectively classified as mild meaning that there was complete agreement 
in the diagnosis of adenomyosis, where adenomyosis was considered to be moderate or 
severe. Given that data from this thesis suggests that adenomyosis only becomes clinically 
significant, at least with regard to menorrhagia and dysmenorrhoea, until more than 2 
ultrasound features are present, this means that there was complete agreement in the 
diagnosis of clinically significant adenomyosis. 
The main strength of this study is that it was a prospective study with pre-defined objectives 
that assessed both inter- and intra-observer agreement. Furthermore, it not only assessed 
agreement of ultrasound diagnosis of adenomyosis, but also agreement in the number of 
ultrasound features seen as well as agreement in classification of severity of adenomyosis. 
A potential weakness is that the numbers are relatively small. Another criticism might be that 
the prevalence of adenomyosis in the population studied was much higher (61.1%) than is 
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likely to be present in a general gynaecology clinic. This was done in order to ensure 
inclusion of stored 3D uterine volumes with a wide range in the number of ultrasound 
features seen in the original real-time scans so as to ensure that reproducibility of 
classification of severity of adenomyosis could be evaluated and to see whether subjective 
ultrasound classification of severity of adenomyosis influenced reproducibility of diagnosis 
of adenomyosis, which it did. 
There has only been one other study assessing the inter-observer variability in diagnosis of 
adenomyosis on transvaginal ultrasound. This study found a considerably lower level of 
inter-observer agreement (kappa=0.38) than we found in our study (Dueholm et al. 2002). 
The study in question collected their data around ten years prior to data collection in our 
study and it may be that technical improvements in TVUS during that time period have led to 
increased resolution and therefore better visualisation of the ultrasound features of 
adenomyosis. 
Consistent with this, is our finding that the intra-observer agreement was better when 
comparing two assessments using stored 3D volumes, then when comparing real-time 
ultrasound scan and an assessment using a stored uterine volume. The higher resolution of 
real-time ultrasound scan may have enabled visualisation of some of the more subtle 
ultrasound features that were not able to be visualised subsequently on 3D stored volumes. 
This may be one of the reasons why some authors have stated that real-time ultrasound 
scanning is mandatory for the accurate diagnosis of adenomyosis (Reinhold et al. 1996). Our 
finding that there was good intra-observer agreement between real-time ultrasound scan and 
stored 3D uterine volume assessment, performed over 3 years apart suggests that accurate 
diagnosis is possible without real-time ultrasound. This has clinical relevance as significant 
expertise in gynaecological ultrasound is required in order to make a diagnosis of 
adenomyosis. If the diagnosis can be made from assessment of stored 3D uterine volumes, 
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then less experienced sonographers who are uncertain of a diagnosis could store a 3D uterine 
volume for assessment by an experienced gynaecological sonographer at a later date. This has 
implications for service provision as it means that experienced sonographers do not have to 
be constantly available to supervise all scans in order for a diagnosis of adenomyosis to be 
made. Furthermore, patients would not need to undergo a second transvaginal ultrasound scan 
in order to confirm the presence of adenomyosis, if the diagnosis can be made on stored 
uterine volumes. 
The inter-observer variability of visualisation of individual ultrasound features of 
adenomyosis was generally good with 3 of the seven features displaying moderate agreement, 
2 displaying good agreement and one displaying perfect agreement. Two of the three features 
with the highest inter-observer variability were asymmetrical myometrial thickening (kappa 
value 0.77) and an irregular EMJ (kappa value 0.65). Data later on in this thesis shows that 
the presence of these two ultrasound features is independently associated with both 
dysmenorrhoea and increasing PBAC-assessed menstrual loss. Future studies should assess 
the real-time inter-observer agreement of ultrasound diagnosis of adenomyosis as well as the 
real-time inter-observer agreement of the individual ultrasound features of adenomyosis.
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[4] HOW COMMON IS ADENOMYOSIS? A PROSPECTIVE STUDY OF 
PREVALENCE USING TRANSVAGINAL ULTRASOUND IN A GYNAECOLOGY 
CLINIC 
 
4.0 DISCUSSION 
The overall prevalence of adenomyosis in our study population was 20.9%. The prevalence 
increased with age reaching a peak of 32% in women aged 40-49. The prevalence was not 
significantly different in pre- and postmenopausal women. On multivariate analysis we found 
that the presence of adenomyosis was significantly associated with age, gravidity and 
endometriosis. 
The main strength of this study is that it was a large prospective study with pre-defined 
objectives and clear diagnostic criteria. All examinations were performed by a single 
observer using high quality, top of the range equipment, which ensured a consistent approach 
to data collection and ultrasound examination, eliminating concerns regarding inter-observer 
variability.  We have also recorded a large number of demographic and clinical variables 
which has enabled us to assess their possible effects on the prevalence of adenomyosis. A 
potential weakness is the lack of histological confirmation of diagnosis in the majority of 
women. In women who underwent a hysterectomy however, histological examination was 
also performed in a detailed, standardised fashion.  The good agreement between pre-
operative ultrasound diagnosis of adenomyosis and histological findings is reassuring and it 
confirms that targeted ultrasound examination can be used in clinical practice for non-
invasive diagnosis of adenomyosis.  
The majority of previous studies evaluating the prevalence of adenomyosis assessed 
populations of women who underwent hysterectomy. The sample sizes were typically very 
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small and they included mainly women with severe symptoms, who were more likely to have 
adenomyosis than asymptomatic women and those with mild symptoms.  In view of this it is 
likely that the prevalence of adenomyosis in these studies was overestimated. Our estimate of 
prevalence of adenomyosis is likely to be closer to the true prevalence in the general 
population of women. As expected the prevalence of adenomyosis in our study was less than 
that in most recent studies (Weiss et al. 2008; Yeniel et al. 2007; Parazzini et al. 2009). In 
order to establish a true prevalence, a screening study involving a large number of unselected 
women would be required, but even then self-selection of women would provide a source of 
bias as those with past or present concerns about their gynaecological health would be more 
likely to volunteer for screening. Our estimate is therefore likely to be slightly higher than the 
genuine prevalence of the condition as we studied symptomatic women attending a 
gynaecology clinic. 
Our finding of good agreement between ultrasound and histology has significant implications 
for clinical practice. Hysterectomy is rarely performed in modern practice for benign 
indications and it is neither practical nor realistic to use histology as a gold standard, in future 
clinical studies of adenomyosis. TVUS and MRI are the only non-invasive diagnostic 
techniques that could be used to investigate the prevalence of adenomyosis in a population of 
women attending outpatient clinics. MRI is much more expensive, time consuming and less 
accessible than ultrasound. In addition, previous studies have not demonstrated that MRI 
provides superior diagnostic accuracy compared to ultrasound (Dueholm 2006). Recent 
studies have shown that ultrasound diagnosis of adenomyosis is sensitive and specific enough 
to employ this technique for in-vivo studies of adenomyosis. The diagnostic criteria we used 
have been assessed previously and they were found to be satisfactory (Kepkep et al. 2007). It 
is therefore likely that in the future, TVUS will be the most common and often the only 
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method, which will be used to make the diagnosis of adenomyosis and monitor its response to 
conservative treatment.  
We found a strong, statistically significant association between adenomyosis and 
endometriosis. Early descriptions of adenomyosis also described an association with 
endometriosis. Indeed, up until the 1920s they were considered to be part of the same entity. 
One recent study (Kunz et al. 2005) suggested that adenomyosis and endometriosis may be 
different expressions of the same pathological process; a process involving abnormal 
peristaltic activity within the inner myometrium. A number of studies have confirmed an 
association between adenomyosis and endometriosis (Bird et al. 1972; Emge 1972), but many 
other have not (Vavilis et al. 1997; Kilkku et al. 1984; Vercellini et al. 1995; Weiss et al. 
2009). A possible explanation for these differences is a tendency to look for the association 
between adenomyosis and endometriosis at the time of hysterectomy. A number of women 
affected by both adenomyosis and endometriosis may have been successfully treated for 
endometriosis in the past. As a result they could be free of active endometriosis at the time of 
hysterectomy, which would typically take place sometime later. Furthermore, three of the 
studies that found no link between adenomyosis and endometriosis were retrospective. There 
are many potential methodological problems with retrospective studies, which could lead to 
under-reporting of endometriosis in study populations. These include the inability to detect 
endometriosis on histological examination of the uterus alone and the risk of under-reporting 
incidental endometriosis at the time of surgery and subsequent histological examination, even 
if the ovaries and fallopian tubes had been removed at the operation. We tried to overcome 
these difficulties by performing a prospective study and by taking into account both a past 
history of endometriosis confirmed at diagnostic laparoscopy and objective evidence of 
endometriosis on the TVUS.  
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Increasing age up to the menopause has long been considered a risk factor for adenomyosis. 
Molitor reported that adenomyosis becomes more common in later reproductive years with a 
decline in the frequency of diagnosis after menopause, however age has not consistently been 
shown to be associated with the disease and more recent studies evaluating age as an 
independent variable have not found an association (Bergholt et al. 2001; Vercellini et al. 
1995; Weiss et al. 2009). These studies, however, are limited in their ability to assess age as 
an independent variable as they draw conclusions from women undergoing hysterectomy, 
who tend to present a relatively narrow age range. The advantage of using a non-invasive 
technique like ultrasound is that it can be applied to a much broader population of women. 
For example, in Bergholt’s study just 31.2% of women were under the age of 45, whereas in 
our study 65.6% of women were under the age of 45. Our findings are therefore more likely 
to provide reliable information about the link between age and prevalence of adenomyosis. 
Many pregnancy-related factors have been linked with adenomyosis including parity 
(Parazzini et al. 1997; Kilkku et al. 1984; Vavilis et al. 1997; Vercellini et al. 1995), 
caesarean delivery (Vavilis et al. 1997; Whitted et al. 2000) and terminations of pregnancy 
(Curtis et al. 2002; Levgur et al. 2000; Vavilis et al. 1997). Again, other studies have not 
replicated these findings (Bergholt et al. 2001; Parazzini et al. 1997; Panganamamula et al. 
2004; Weiss et al. 2009). The univariate analysis in our study suggested that gravidity, parity, 
uterine instrumentation during pregnancy, spontaneous miscarriage, vaginal delivery and 
caesarean delivery were all associated with adenomyosis. After multivariate analysis only 
gravidity was found to be significantly associated with adenomyosis, although parity was not 
included in the multivariate analysis as analysis suggested it was co-linear with the other 
variables. This finding suggests that it may be the presence of a pregnancy rather than the 
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specifics of what occurs in any given pregnancy that may play a role in the development of 
adenomyosis.  
Body mass index, intrauterine contraceptive device use, use of the progesterone-only 
contraceptive pill, vaginal or caesarean section delivery, miscarriage and either evacuation of 
retained products of conception or surgical termination of pregnancy all appeared to be 
significantly associated with adenomyosis prior to the multivariate analysis. It is likely that 
age accounted for most of these trends and that once the data were adjusted for age the 
significance was no longer seen. An important finding was the absence of a significant 
difference in the prevalence of adenomyosis between pre- and post-menopausal women. The 
prevalence of adenomyosis in postmenopausal women, however was less when compared to 
the prevalence in the group of women aged 40-49, when the condition was found to be most 
prevalent. This indicates that adenomyosis tends to regress after menopause, but still remains 
detectable in a significant number of women. Others have described a similar relationship 
(Kitawaki 2006). Kitawaki also noted that no studies have shown that use of the combined 
oral contraceptive pill causes regression of adenomyosis. Our data adds further weight to this 
and showed that there was no association between use of the combined oral contraceptive pill 
and the presence of adenomyosis. 
Adenomyosis is a common condition and yet little is known about its aetiology, natural 
history and clinical significance. This was largely due to the inability to make a conclusive 
and accurate diagnosis of adenomyosis in the past using non-invasive diagnostic methods.  
Our study, and other recent studies, has shown that transvaginal ultrasound is an accurate 
method to diagnose adenomyosis.  Due to its wide availability and acceptability, ultrasound 
could be used to facilitate large scale studies of adenomyosis in different populations of 
women.  Future research should try to elucidate its natural history and to examine possible 
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associations between adenomyosis and different clinical symptoms including subfertility.  
This information should help to develop more effective preventative and treatment strategies 
in women affected by adenomyosis. 
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[5] IS ADENOMYOSIS ASSOCIATED WITH MENORRHAGIA? 
5.0 DISCUSSION 
Our results did not show a significant association between the presence of adenomyosis and 
menorrhagia on multivariable analysis. There was, however, a statistically significant positive 
correlation between amount of menstrual loss and the number of ultrasound features of 
adenomyosis seen. Other independent variables associated with menorrhagia included 
fibroids, in particular sub-mucous fibroids, endometrial polyps, gravidity and BMI. Sub-
mucous fibroids were found to have the strongest association with menorrhagia. 
The main strength of our study was that ultrasound rather than histology was used to 
diagnosis uterine pathology which helped to reduce selection bias. This also allowed the 
inclusion of a relatively large number of women with a greater range of symptoms and 
varying degrees of severity of adenomyosis who are likely, therefore, to be more 
representative of the population of women attending gynaecology clinics. In addition, this 
was a prospective study with clearly defined inclusion criteria and a standardised approach to 
the ultrasound examinations which were all performed by a single highly-trained operator 
using advanced, modern ultrasound equipment.  
While two different assessments of menstrual loss were used, both methods had limitations. 
The subjective binary assessment of menorrhagia is simple to measure and easy to assess in a 
large population, however studies have shown that self-assessed menorrhagia may not be an 
accurate measure of excessive menstrual blood loss (Chimbira et al. 1980). Nevertheless, the 
use of a subjective assessment of menorrhagia is consistent with recent national guidance 
(NICE 2007) for clinicians. PBACs offer a relatively simple alternative to the more arduous 
and time-consuming laboratory methods of objectively measuring menstrual blood loss. It 
must be remembered however, that they are not as accurate and remain a subjective 
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assessment of menstrual blood loss. Furthermore, there are limitations to the way they were 
used in our study. It has been estimated that women may experience 20%-40% variation in 
menstrual loss between different periods (Hallberg & Nilsson 1964). The fact that PBACs 
were only used for one menstrual cycle in our study may therefore have limited the validity 
of the PBAC assessment. Another limitation in our use of PBACs is the fact that women 
filled in the charts based on usage with their own sanitary wear, which will be of variable 
absorbency across the study population. Studies have generally addressed this issue by 
providing standardised sanitary wear. We chose not do so for reasons of practicality and cost.  
Despite these limitations the ease of use of PBACs enabled us to make a semi-quantitative 
assessment of menstrual loss in a large population. Furthermore, by making a semi-
quantitative assessment of menstrual blood loss, their use allowed us to take account of the 
severity of menorrhagia in the study population.There was a fair level of agreement between 
both assessments of menorrhagia so we used both methods in data analysis. 
There is a lack of consensus in the literature regarding the relationship between adenomyosis 
and menorrhagia. This is not surprising bearing in mind that the majority of studies were 
retrospective in nature and mainly included populations of women undergoing hysterectomy. 
These studies used differing criteria for the diagnosis of adenomyosis and few of them 
attempted to quantify severity of disease. In addition, none of the studies controlled for the 
presence of concomitant pathology and their potential effect on the volume of menstrual loss. 
Our study has clearly shown that severity of adenomyosis, as measured by the number of 
different ultrasound features of adenomyosis seen, correlates with the amount of menstrual 
loss. The severity of adenomyosis is difficult to express in quantitative terms as the lesions 
are often poorly defined and they may be disseminated throughout different parts of the 
myometrium. Levgur et al. used depth of foci of adenomyosis on histological examination to 
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assess severity of disease in their retrospective study (Levgur et al. 2000). While this study 
had relatively small numbers and used retrospective case note analysis to define menorrhagia, 
it was still able to uncover an association between severity of adenomyosis and menorrhagia.  
Not only did our study show a positive association between the number of ultrasound features 
of adenomyosis seen and increasing PBAC-assessed menstrual loss, it also showed that some 
of the individual ultrasound features of adenomyosis were independently associated with 
increasing PBAC-assessed menstrual loss. Asymmetrical myometrial thickening and an 
irregular EMJ were both independently associated with PBAC assessed menstrual loss. It is 
not surprising that asymmetrical myometrial thickening has a greater effect on symptoms 
than other ultrasound features, as it is by definition, only seen when the disease is severe 
enough to have affected an entire wall of the uterus. This is in contrast to some of the other 
features, such as linear striations, that may affect only a small volume of the uterus. 
Irregularity of the EMJ may have a greater impact on menstrual loss than other features 
because any pathological effect is occurring at the interface where blood loss occurs, in 
contrast to myometrial cysts, for example, that by definition occur some distance from the 
endometrium. Despite the fact that some features appear to have a greater impact on 
menstrual loss than others, we think that it is better to express severity of adenomyosis semi-
quantitatively using the number of different morphological features alone in an individual 
woman as an indirect measure of severity of disease. Any proposed system to formally grade 
severity of adenomyosis based on the number or type of features seen needs to be 
prospectively assessed before it can be brought into widespread clinical use. 
The recognition that the severity of a condition is important when assessing clinical impact 
has already been adopted in clinical practice when studying the effect of fibroids on 
menstrual loss. It has been generally accepted that fibroids cause menorrhagia and that their 
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size and location determines their clinical significance (NICE 2007). Our study has also 
confirmed that the location of fibroids is a critical diagnostic feature as submucous fibroids 
were found to have a much more severe effect on menstrual loss than fibroids in other 
locations. It is also known however, that the majority of fibroids are asymptomatic (Divakar 
2008). Furthermore, there is a surprisingly small amount of evidence showing an association 
between fibroids and menorrhagia (Parker 2007). While early reports (Miller et al. 1953) 
ascribed heavy periods to submucous fibroids only, others have found that neither the 
number, volume or location of fibroids were related to menstrual characteristics (Marino et 
al. 2004). This study was however, relatively small and did not have enough numbers to 
assess the effect of submucous fibroids. A larger study in which the population had a higher 
prevalence of fibroids found an association between both length of menses and “gushing 
bleeding” and the size of fibroids but not the number or their location (Wegienka et al. 2003). 
This study however, used telephone interviews as a means of assessing patient symptoms. 
Our study had a large sample size, used high quality ultrasound to assess the exact location of 
the fibroids and used both objective and semi-quantitative methods to measure menstrual 
loss. It is likely therefore, that our findings that fibroids are associated with heavy periods and 
that this association is stronger with sub-mucous fibroids, are accurate. A long-standing 
difficulty in assessing the association of fibroids and adenomyosis on menorrhagia is the 
potentially confounding effect that both conditions will have on each other, with both the 
prevalence and the burden of both conditions being positively associated with advancing age 
(Naftalin et al. 2012b; Mavrelos et al. 2010). By combining a thorough ultrasound assessment 
looking for all uterine pathologies with multiple demographic and clinical factors before 
using multivariate logistic regression analysis, our study was able to account for this 
potentially confounding effect. 
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Other variables found to be associated with menorrhagia in our study include endometrial 
polyps, increasing gravidity and increasing BMI. While endometrial polyps are frequently 
cited as a cause of menorrhagia (Munro et al. 2011), many studies have merely found a 
higher than expected prevalence of endometrial polyps in symptomatic populations of women 
and extrapolated causation. The only study that compared symptomatic women to 
asymptomatic women found a significantly higher prevalence of polyps in women with 
abnormal menstrual bleeding, however this study included women with prolonged periods 
and polymenorrhoea as well as women with menorrhagia. Furthermore, the authors 
concluded that small endometrial polyps are frequently asymptomatic (Clevenger-Hoeft et al. 
1999). One study used PBACs to measure menstrual loss before and after performing 
hysteroscopic polypectomy and found that post-procedure, there was a significant reduction 
in menstrual loss (van Dongen et al. 2009). This suggests that endometrial polyps contribute 
significantly to menstrual loss and is in keeping with our finding that they are significantly 
associated with both PBAC-assessedand subjectively measured menorrhagia. 
While there are little data assessing the effect of increasing BMI on menorrhagia, it is known 
that the peripheral conversion of adrenal and gonadal androgens to oestrogens in peripheral 
tissue is greater in obese women (Siiteri 1987). The increased endometrial proliferation 
caused by this oestrogen excess is known to progress to endometrial hyperplasia and 
endometrial cancer. Endometrial proliferation would also be expected to cause increased 
menstrual flow. Our study cannot explain the association between increasing gravidity and 
menorrhagia. It could be postulated that the increased blood loss may be due to the increase 
in uterine size seen with increasing gravidity (Verguts et al. 2013), however Rees et al. found 
no correlation between measured menstrual blood loss and endometrial volume-to-surface 
ratio (Rees et al. 1984). 
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[6] IS ADENOMYOSIS ASSOCIATED WITH DYSMENORRHOEA? 
6.0 DISCUSSION  
On multivariate analysis we found adenomyosis and endometriosis both had a significant 
independent positive correlation with dysmenorrhoea. There was also a positive correlation 
between the number of ultrasound features of adenomyosis seen and NRS score for painful 
periods. 
The main strengths of our study were that ultrasound was used to diagnosis adenomyosis, 
minimising the heavy selection bias seen when histology is used to assess symptomatology in 
the past. This also allowed for the inclusion of a relatively large number of women. All the 
scans were performed using top of the range equipment by a single operator who was 
prospectively looking for the presence of adenomyosis. A further strength of the study was 
the use of a validated, reproducible pain scoring system to assess the extent of 
dysmenorrhoea. A potential weakness is the lack of histological confirmation of diagnosis in 
the majority of women studied however, in those women in the study population who 
underwent hysterectomy there was good agreement between ultrasound and histological 
diagnosis (Naftalin et al. 2012b). 
Our finding that adenomyosis was significantly associated with pain symptoms, is neither 
new, nor surprising. The first detailed description of adenomyosis by Cullen over a century 
ago described one of the main symptoms as being a ‘great deal of pain’ (Cullen 1908). Many 
subsequent authors have described a similar clinical picture involving painful periods in 
women with adenomyosis (Emge 1962; Bird et al. 1972; Benson and Sneedon 1958). 
However, several authors have found no association between the presence of adenomyosis 
and pain-related symptoms (Bergholt et al. 2001; Parazzini et al. 1997; Weiss et al. 2009).  
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An important contributor to these conflicting reports is the use of histology as the means to 
diagnose adenomyosis. Pain symptoms have historically been a common indication for 
hysterectomy. Thus the hysterectomized population are significantly more likely to have pain 
symptoms than those women with an intact uterus. This makes it harder to show a significant 
difference in symptomatology between two groups undergoing hysterectomy. A recent study 
looking only at perimenopausal women undergoing hysterectomy (Weiss et al. 2009) having 
failed to show a significant difference in symptomatology between women found on 
histological examination to have adenomyosis and those who did not, concluded that 
adenomyosis was not a “disease per se, but rather a normal variant”. This study, as with most 
other studies on the subject, used retrospective case note analysis to assess pain symptoms 
and assessed them as a binary outcome only. By using a quantitative assessment of pain our 
study was able to take account of severity of dysmenorrhoea in the data analysis and hence 
our findings are likely to be more accurate. 
A further obstacle in assessing the association between adenomyosis and dysmenorrhoea is 
dealing with the confounding effect of endometriosis. Both conditions are a recognised cause 
of dysmenorrhoea and studies have revealed a strong association between the two conditions 
(Naftalin et al. 2012b). By performing a thorough pelvic ultrasound assessment looking for 
the presence of ultrasound features of adenomyosis  as well as direct and indirect features of 
endometriosis, prior to using multivariable logistic regression analysis, our study was able to 
account for this potentially confounding effect. 
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[7] EVALUATION OF A SECOND-STAGE TEST DESIGNED TO IMPROVE THE 
ACCURACY OF TRANSVAGINAL ULTRASOUND IN THEDIAGNOSIS OF 
ENDOMETRIAL CANCER 
 
7.0 DISCUSSION 
We have shown that a second-stage ultrasound test applied to women presenting with 
postmenopausal bleeding and either an endometrial thickness >5mm or focal pathology, can 
significantly improve the specificity of ultrasound diagnosis of endometrial cancer. There are 
a number of advantages to being able to more accurately diagnose endometrial cancer in 
women with postmenopausal bleeding. It allows more efficient triaging of women with 
postmenopausal bleeding for invasive diagnostic testing. Without application of the second-
stage test, women identified with focal endometrial lesions would normally have to wait for a 
hysteroscopy, which might take weeks, before reaching a tissue diagnosis. The identification 
of women with focal endometrial lesions with appearances suggesting a higher risk of 
endometrial cancer, facilitates same-day outpatient endometrial sampling, for example pipelle 
biopsy, which has been shown to have a sensitivity of 99.6% in detecting endometrial cancer 
(Dijkhuizen et al. 2000). This would speed up the diagnostic process and reduce the time 
from presentation to treatment in those women, while reducing the total number of 
hysteroscopies required. This would both reduce the overall risk associated with diagnostic 
invasive procedures while also reducing service costs and waiting times. 
The post-test odds of endometrial cancer in women with homogenous, avascular endometria 
and an intact EMJ are low (0.025). While this study is insufficient to conclude that an 
endometrial sample would not be required in this group, it could provide significant 
reassurance to patients and reduce the time-pressure for endometrial sampling in women 
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found to be low risk for endometrial cancer, despite having a thickened endometrium. 
Endometrial sampling could even be avoided in this group if, due to other co-morbidities, the 
invasive procedures required to get one represented too significant a risk.  
Various endometrial ultrasound criteria have been assessed in attempts to improve the 
specificity of ultrasound in diagnosing endometrial cancer with mixed results. A study by 
Randelzhofer et al. agreed with our finding that endometrial morphology and regularity of the 
EMJ were useful criteria to differentiate benign and malignant endometria (Randelzhofer et 
al. 2002). In contrast, other investigators (Epstein et al. 2001; Epstein et al. 2002) concluded 
in two separate studies that there was significant overlap of ultrasound morphology between 
benign and malignant endometrial lesions. A later study by the same research group (Epstein 
and Valentin 2006) did find that heterogeneous echogenicity and an irregular surface of 
endometrial lesions on B-mode ultrasound scan were useful criteria for diagnosing 
endometrial malignancy in women with thickened endometria, but only when there was fluid 
within the uterine cavity. Differences in study design and population may explain why their 
conclusions differ from ours. Our population (mean age 59 years v 65 years) was younger 
and had a greater proportion of malignancies staged 2 or above (36.4% v 9.1%). Their study 
population also included women taking HRT whereas both our study and the study by 
Randelzhofer excluded patients taking HRT (Randelzhofer et al. 2002). Lastly, in their 
analysis, heterogeneous endometrium was close to statistical significance (P=0.08) and as the 
authors themselves concluded, it may just have been that their study was underpowered to 
detect a true difference as being statistically significant. 
There have been similarly contrasting results from studies assessing the use of Doppler as a 
means to improve the accuracy of ultrasound in diagnosing endometrial cancer. Early studies 
using colour Doppler reported promising results in the diagnosis of endometrial cancer. 
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Bourne et al. used colour Doppler to measure and compare the pulsatility indices (PI) of the 
uterine arteries in 34 women with postmenopausal bleeding. They found that the PI was 
reduced in the 17 women subsequently found to have endometrial cancer and concluded that 
Doppler had great potential in the assessment of uterine pathology (Bourne et al. 1991). It is 
unclear however, from their methods, how women were selected for the study. Furthermore, 
the prevalence of endometrial cancer in the study population (50%) was much greater than in 
most other studies of women with postmenopausal bleeding. Subsequent studies of Doppler 
flow both in the uterine and endometrial arteries (Sladkevicius et al. 1994; Sheth et al. 1995) 
have been unable to show that Doppler is useful in discriminating between benign and 
malignant endometrial lesions. 
Timmerman et al. showed that using colour Doppler to assess the distribution of blood 
vessels supplying focal endometrial lesions was helpful in the diagnosis of endometrial 
polyps (Timmerman et al. 2003), but they excluded women with a suspicion or confirmed 
endometrial cancer. Alcazar et al reported that in more than 80% of cases of endometrial 
cancer, a particular power Doppler pattern of vasculature could be observed (Alcazar et al. 
2003). Epstein et al. used an algorithm including power Doppler assessment of endometrial 
vascularity to estimate the risk of endometrial malignancy. They concluded that their 
algorithm was better than subjective assessment at differentiating benign and malignant 
endometria in women with an endometrial thickness of 5-15mm, although this conclusion did 
not reach statistical significance (Epstein et al. 2002). Subsequent work by the same research 
group was unable to show that using colour Doppler to assess the number of blood vessels 
within the endometrium aided the diagnosis of malignancy in women with postmenopausal 
bleeding (Epstein and Valentin 2006). In contrast to our study however, they assessed the 
number of vessels seen within the endometrium as a whole. It may be that in order for colour 
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Doppler assessment of vascular morphology to be helpful, it needs to be limited to 
assessment of the number of vessels crossing the EMJ at the site of any endometrial 
irregularity or focal lesion.  
Any test including assessment of endometrial morphology and/or Doppler examination will 
be limited by the fact that these methods are subjective. Furthermore, there were a relatively 
small number of women included our study. While, these results would need to be 
reproduced in larger numbers and in a different population prior to being introduced in a 
clinical setting, we have nevertheless shown that a large increase in the specificity of 
ultrasound in diagnosing endometrial cancer is possible without a large drop in sensitivity. 
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 PART V Conclusions and further research 
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This thesis has explored aspects of the ultrasound assessment of the EMJ. It has shown that a 
classification of EMJ visualisation based on 3D ultrasound is reproducible and is therefore 
feasible to use in clinical practice. Endometrial thickness and parity have been shown to be 
significantly associated with quality of EMJ visualisation. These findings however, only 
relate to normal uteri and further work is required to assess what pathological variables affect 
EMJ visualisation. 
In contrast to other work, it was found that there was a good level of intra- and interobserver 
agreement in the ultrasound diagnosis of adenomyosis. This was the case when real-time 
ultrasound assessments were compared with assessments made from stored uterine volumes, 
as well as when both assessments were made from stored volumes. Arguments against the 
use of TVUS for the pre-operative diagnosis of adenomyosis have centred on inadequate 
levels of inter-observer agreement and the reported necessity of real-time images to make the 
diagnosis. This finding strengthens the case for TVUS to be the pre-operative imaging 
modality of choice. It is also helpful to the clinician and to the patient, allowing a second 
opinion to be sought, in cases of uncertainty, without recourse to a second scan. Further work 
should focus on assessing the inter-observer agreement of TVUS in the diagnosis of 
adenomyosis when two real-time scans are performedon the same occasion. 
TVUS was used to estimate the prevalence of adenomyosis in women attending a general 
gynaecology clinic in a large prospective observational study. The prevalence was estimated 
to be 20.9%. It was also found that age, gravidity and pelvic endometriosis were all 
significantly associated with the presence of adenomyosis. Better estimates of the prevalence 
of adenomyosis using TVUS could help improve understanding of the burden of the disease, 
in particular with regard to menstrual symptoms, pain symptoms and subfertility. 
Furthermore, more accurate estimates of the prevalence of adenomyosis will lead to more 
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accurate assessment of the associations of the disease and will therefore aid studies in the 
future looking to identify women at increased risk of developing the condition. 
TVUS was also used to investigate whether adenomyosis was associated with menstrual 
symptoms. Subjective assessments of dysmenorrhoea were used to look for an association 
between adenomyosis and dysmenorrhoea. Multivariable analysis revealed that both 
endometriosis and adenomyosis were independently associated with dysmenorrhoea. Both 
subjective and semi-quantitative assessments of menorrhagia were used in the same 
population to investigate if adenomyosis was associated with menorrhagia. Multivariable 
analysis showed that while adenomyosis was not significantly associated with menorrhagia 
when assessed as a binary outcome, when severity of disease was taken into account, there 
was a significant association. In both studies, severity of disease was based on the number of 
ultrasound features of adenomyosis seen. While this classification system has revealed 
insights into the relationship between adenomyosis and menstrual symptoms, its validity 
remains uncertain. A prospective evaluation is required. 
Lastly, the role of a second-stage ultrasound test incorporating assessment of the EMJ in the 
diagnosis of endometrial cancer in women presenting with post-menopausal bleeding was 
investigated. Its use was found to significantly increase the specificity of ultrasound while 
having a minimal effect on sensitivity. It must however be noted that the sample size was 
small. 
This thesis has, I hope, set a new benchmark for the ultrasound assessment of both the EMJ 
and the uterine diseases adenomyosis and endometrial cancer. By incorporating 3D 
ultrasound assessment with a more detailed analysis of the EMJ and the individual ultrasound 
features of adenomyosis, this thesis has increased our understanding of the EMJ, 
adenomyosis and paved the way for a new way of triaging women with post-menopausal 
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bleeding. It should also facilitate future work on adenomyosis and the EMJ. Key areas for 
further investigation are the prospective development of a clinically relevant ultrasound 
grading system for the severity of adenomyosis, the role of adenomyosis in subfertility and a 
comparison of the current model of assessing women with post-menopausal bleeding with the 
the second-stage test used in this thesis to assess women with post-menopausal bleeding. 
Application of the ultrasound assessment used in this thesis to subfertile women could help 
determine how severity of adenomyosis affects fertility and also the impact of individual 
ultrasound features of adenomyosis on fertility. Continuation of this work in subfertile 
women who then conceive could provide novel information on the impact of adenomyosis on 
obstetric outcomes.
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